Neutrophils as potential therapeutic targets in hepatocellular carcinoma
The success of atezolizumab plus bevacizumab treatment contributed to a shift in systemic therapies for hepatocellular carcinoma (HCC) towards combinations that include cancer immunotherapeutic agents. Thus far, the principal focus of cancer immunotherapy has been on interrupting immune checkpoints...
Saved in:
Published in | Nature reviews. Gastroenterology & hepatology Vol. 19; no. 4; pp. 257 - 273 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.04.2022
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The success of atezolizumab plus bevacizumab treatment contributed to a shift in systemic therapies for hepatocellular carcinoma (HCC) towards combinations that include cancer immunotherapeutic agents. Thus far, the principal focus of cancer immunotherapy has been on interrupting immune checkpoints that suppress antitumour lymphocytes. As well as lymphocytes, the HCC environment includes numerous other immune cell types, among which neutrophils are emerging as an important contributor to the pathogenesis of HCC. A growing body of evidence supports neutrophils as key mediators of the immunosuppressive environment in which some cancers develop, as well as drivers of tumour progression. If neutrophils have a similar role in HCC, approaches that target or manipulate neutrophils might have therapeutic benefits, potentially including sensitization of tumours to conventional immunotherapy. Several neutrophil-directed therapies for patients with HCC (and other cancers) are now entering clinical trials. This Review outlines the evidence in support of neutrophils as drivers of HCC and details their mechanistic roles in development, progression and metastasis, highlighting the reasons that neutrophils are well worth investigating despite the challenges associated with studying them. Neutrophil-modulating anticancer therapies entering clinical trials are also summarized.
Growing evidence indicates that neutrophils are involved in tumorigenesis, progression and metastasis of hepatocellular carcinoma (HCC). Here, Geh and colleagues summarize neutrophil phenotypes in HCC, describe the pathogenetic mechanisms underlying these contributions of neutrophils to HCC and highlight emerging neutrophil-targeted therapies.
Key points
A growing body of evidence identifies neutrophils as central to the pathogenesis of hepatocellular carcinoma (HCC) and as having important roles in tumorigenesis, local tumour progression and metastasis.
The main mechanisms by which neutrophils drive tumour progression are immunosuppression, direct enhancement of tumour cell survival, invasiveness and metastatic capacity, extracellular matrix remodelling and angiogenesis.
Single-cell technologies show that neutrophils probably have a dynamic spectrum of pro-tumour and antitumour functions that vary according to their microenvironment; as such, the current phenotypic classification should be revisited.
Preclinical studies demonstrate that targeting neutrophils is an effective strategy in HCC: therapies that selectively target tumour-promoting neutrophil functions, signalling pathways and chemotaxis are currently under investigation.
Manipulation of neutrophil function could potentially render the HCC immune microenvironment more permissive to systemic immunotherapies.
Further work, including improvements in preclinical models and single-cell technologies, is needed to determine the phenotypes of neutrophils in HCC and in chronic liver diseases. |
---|---|
AbstractList | The success of atezolizumab plus bevacizumab treatment contributed to a shift in systemic therapies for hepatocellular carcinoma (HCC) towards combinations that include cancer immunotherapeutic agents. Thus far, the principal focus of cancer immunotherapy has been on interrupting immune checkpoints that suppress antitumour lymphocytes. As well as lymphocytes, the HCC environment includes numerous other immune cell types, among which neutrophils are emerging as an important contributor to the pathogenesis of HCC. A growing body of evidence supports neutrophils as key mediators of the immunosuppressive environment in which some cancers develop, as well as drivers of tumour progression. If neutrophils have a similar role in HCC, approaches that target or manipulate neutrophils might have therapeutic benefits, potentially including sensitization of tumours to conventional immunotherapy. Several neutrophil-directed therapies for patients with HCC (and other cancers) are now entering clinical trials. This Review outlines the evidence in support of neutrophils as drivers of HCC and details their mechanistic roles in development, progression and metastasis, highlighting the reasons that neutrophils are well worth investigating despite the challenges associated with studying them. Neutrophil-modulating anticancer therapies entering clinical trials are also summarized. The success of atezolizumab plus bevacizumab treatment contributed to a shift in systemic therapies for hepatocellular carcinoma (HCC) towards combinations that include cancer immunotherapeutic agents. Thus far, the principal focus of cancer immunotherapy has been on interrupting immune checkpoints that suppress antitumour lymphocytes. As well as lymphocytes, the HCC environment includes numerous other immune cell types, among which neutrophils are emerging as an important contributor to the pathogenesis of HCC. A growing body of evidence supports neutrophils as key mediators of the immunosuppressive environment in which some cancers develop, as well as drivers of tumour progression. If neutrophils have a similar role in HCC, approaches that target or manipulate neutrophils might have therapeutic benefits, potentially including sensitization of tumours to conventional immunotherapy. Several neutrophil-directed therapies for patients with HCC (and other cancers) are now entering clinical trials. This Review outlines the evidence in support of neutrophils as drivers of HCC and details their mechanistic roles in development, progression and metastasis, highlighting the reasons that neutrophils are well worth investigating despite the challenges associated with studying them. Neutrophil-modulating anticancer therapies entering clinical trials are also summarized.Growing evidence indicates that neutrophils are involved in tumorigenesis, progression and metastasis of hepatocellular carcinoma (HCC). Here, Geh and colleagues summarize neutrophil phenotypes in HCC, describe the pathogenetic mechanisms underlying these contributions of neutrophils to HCC and highlight emerging neutrophil-targeted therapies. The success of atezolizumab plus bevacizumab treatment contributed to a shift in systemic therapies for hepatocellular carcinoma (HCC) towards combinations that include cancer immunotherapeutic agents. Thus far, the principal focus of cancer immunotherapy has been on interrupting immune checkpoints that suppress antitumour lymphocytes. As well as lymphocytes, the HCC environment includes numerous other immune cell types, among which neutrophils are emerging as an important contributor to the pathogenesis of HCC. A growing body of evidence supports neutrophils as key mediators of the immunosuppressive environment in which some cancers develop, as well as drivers of tumour progression. If neutrophils have a similar role in HCC, approaches that target or manipulate neutrophils might have therapeutic benefits, potentially including sensitization of tumours to conventional immunotherapy. Several neutrophil-directed therapies for patients with HCC (and other cancers) are now entering clinical trials. This Review outlines the evidence in support of neutrophils as drivers of HCC and details their mechanistic roles in development, progression and metastasis, highlighting the reasons that neutrophils are well worth investigating despite the challenges associated with studying them. Neutrophil-modulating anticancer therapies entering clinical trials are also summarized. Growing evidence indicates that neutrophils are involved in tumorigenesis, progression and metastasis of hepatocellular carcinoma (HCC). Here, Geh and colleagues summarize neutrophil phenotypes in HCC, describe the pathogenetic mechanisms underlying these contributions of neutrophils to HCC and highlight emerging neutrophil-targeted therapies. Key points A growing body of evidence identifies neutrophils as central to the pathogenesis of hepatocellular carcinoma (HCC) and as having important roles in tumorigenesis, local tumour progression and metastasis. The main mechanisms by which neutrophils drive tumour progression are immunosuppression, direct enhancement of tumour cell survival, invasiveness and metastatic capacity, extracellular matrix remodelling and angiogenesis. Single-cell technologies show that neutrophils probably have a dynamic spectrum of pro-tumour and antitumour functions that vary according to their microenvironment; as such, the current phenotypic classification should be revisited. Preclinical studies demonstrate that targeting neutrophils is an effective strategy in HCC: therapies that selectively target tumour-promoting neutrophil functions, signalling pathways and chemotaxis are currently under investigation. Manipulation of neutrophil function could potentially render the HCC immune microenvironment more permissive to systemic immunotherapies. Further work, including improvements in preclinical models and single-cell technologies, is needed to determine the phenotypes of neutrophils in HCC and in chronic liver diseases. |
Author | Leslie, Jack Rumney, Rob Reeves, Helen L. Geh, Daniel Mann, Derek A. Bird, Thomas G. |
Author_xml | – sequence: 1 givenname: Daniel orcidid: 0000-0002-3592-7469 surname: Geh fullname: Geh, Daniel organization: Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University – sequence: 2 givenname: Jack surname: Leslie fullname: Leslie, Jack organization: Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University – sequence: 3 givenname: Rob surname: Rumney fullname: Rumney, Rob organization: School of Pharmacy, Faculty of Medical Sciences, Newcastle University – sequence: 4 givenname: Helen L. orcidid: 0000-0003-0359-9795 surname: Reeves fullname: Reeves, Helen L. organization: Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, The Liver Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Hepatopancreatobiliary Multidisciplinary Team, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital – sequence: 5 givenname: Thomas G. surname: Bird fullname: Bird, Thomas G. organization: Cancer Research UK Beatson Institute, MRC Centre for Inflammation Research, University of Edinburgh – sequence: 6 givenname: Derek A. orcidid: 0000-0003-0950-243X surname: Mann fullname: Mann, Derek A. email: derek.mann@newcastle.ac.uk organization: Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Department of Gastroenterology and Hepatology, School of Medicine, Koç University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35022608$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kD1PwzAURS1UxEfhDzCgSCwsgeePl8QjQkCRKlhgthzXaYPSONjOwL_HpQUkBibbesfnXd1jMuldbwk5o3BFgVfXQVAsMQdGcwAsqhz3yBEtUeYIyCc_d4GH5DiEN4ACkcsDcsgRGCugOiKzJztG74ZV24VMh2xw0fax1V0WV9brIU1bk0XtlzaGrO2zlR10dMZ23dhpnxntTdu7tT4h-43ugj3dnVPyen_3cjvL588Pj7c389wIKmNKU5fMNDQ90FBe1MaUXFSylkw0mjHLtSybqkEoocEFq2uKQjeLgmoDIAWfksutd_DufbQhqnUbNnF0b90YFCuSWTCQmNCLP-ibG32f0iVKYFlIxiFRbEsZ70LwtlGDb9fafygKatOz2vasUs_qq2e1UZ_v1GO9toufL9_FJoBvgZBG_dL6393_aD8BgOKJ2A |
CitedBy_id | crossref_primary_10_1016_j_jhep_2023_03_038 crossref_primary_10_3389_fimmu_2022_951406 crossref_primary_10_1016_j_jhepr_2024_101130 crossref_primary_10_1007_s12613_023_2717_3 crossref_primary_10_1042_EBC20220245 crossref_primary_10_1097_HEP_0000000000000890 crossref_primary_10_1155_2022_8284500 crossref_primary_10_3389_fonc_2022_1032579 crossref_primary_10_3389_fonc_2022_892510 crossref_primary_10_3389_fgene_2022_965805 crossref_primary_10_1002_cam4_5773 crossref_primary_10_2139_ssrn_4162719 crossref_primary_10_3390_ijms24087463 crossref_primary_10_2147_JHC_S441672 crossref_primary_10_3390_medicina60050716 crossref_primary_10_1038_s41598_023_46132_w crossref_primary_10_3390_cancers14102469 crossref_primary_10_3389_fgene_2022_989779 crossref_primary_10_1016_j_bbcan_2023_188931 crossref_primary_10_3389_fonc_2022_1025805 crossref_primary_10_1111_sji_13327 crossref_primary_10_3389_fmolb_2023_1210111 crossref_primary_10_1038_s41598_024_54115_8 crossref_primary_10_1016_j_biomaterials_2024_122481 crossref_primary_10_1016_j_bios_2023_115721 crossref_primary_10_1080_17474124_2023_2212161 crossref_primary_10_1021_cbmi_3c00105 crossref_primary_10_3390_ijms25010181 crossref_primary_10_3389_fimmu_2023_1253964 crossref_primary_10_3389_fonc_2023_1204335 crossref_primary_10_1007_s00262_023_03567_4 crossref_primary_10_3389_fonc_2023_1142168 crossref_primary_10_1016_j_jhep_2024_02_009 crossref_primary_10_1136_gutjnl_2022_327924 crossref_primary_10_3390_ijms242417583 crossref_primary_10_1136_gutjnl_2021_326259 crossref_primary_10_1002_ctd2_171 crossref_primary_10_1038_s41571_024_00868_0 crossref_primary_10_1007_s13577_024_01024_7 crossref_primary_10_1016_j_jconrel_2024_01_050 crossref_primary_10_1158_0008_5472_CAN_23_2986 crossref_primary_10_1007_s00432_023_05315_8 crossref_primary_10_2147_JHC_S432134 crossref_primary_10_1007_s12032_023_01948_4 crossref_primary_10_3389_fonc_2022_975981 crossref_primary_10_1016_j_intimp_2023_111136 crossref_primary_10_1016_j_jcmgh_2024_03_001 crossref_primary_10_1186_s13045_023_01452_2 crossref_primary_10_1136_gutjnl_2022_329322 crossref_primary_10_3389_fimmu_2023_1125874 crossref_primary_10_1007_s10238_023_01059_4 crossref_primary_10_1002_lci2_70 crossref_primary_10_12677_acm_2024_143917 crossref_primary_10_1038_s41467_024_46118_w crossref_primary_10_1016_j_jhep_2024_02_017 crossref_primary_10_7717_peerj_15373 crossref_primary_10_1055_s_0044_1787152 crossref_primary_10_3389_fimmu_2023_1211399 crossref_primary_10_1002_ctm2_1599 crossref_primary_10_3390_cancers15133327 crossref_primary_10_3390_biology12070941 crossref_primary_10_3390_cells12010202 crossref_primary_10_1039_D4LC00341A crossref_primary_10_1021_acsnano_4c00392 crossref_primary_10_1038_s41571_023_00816_4 crossref_primary_10_1002_mco2_325 crossref_primary_10_1371_journal_pone_0298775 crossref_primary_10_3389_fimmu_2023_1204338 crossref_primary_10_3389_fimmu_2022_983490 crossref_primary_10_1186_s40164_024_00521_7 crossref_primary_10_1016_j_biopha_2024_116670 crossref_primary_10_1186_s12967_024_05389_z crossref_primary_10_2147_JHC_S460922 crossref_primary_10_1016_j_intimp_2024_112253 crossref_primary_10_1186_s13045_024_01549_2 crossref_primary_10_1038_s41392_023_01462_z crossref_primary_10_1016_j_biopha_2023_114798 crossref_primary_10_1002_cnr2_1684 crossref_primary_10_3389_fmolb_2023_1242059 crossref_primary_10_1158_1078_0432_CCR_21_2517 crossref_primary_10_1016_j_heliyon_2024_e29099 crossref_primary_10_1186_s12885_024_11904_8 crossref_primary_10_1038_s41467_024_45215_0 crossref_primary_10_3390_pharmaceutics14091760 crossref_primary_10_1186_s40001_022_00900_y crossref_primary_10_3389_fgene_2022_921195 crossref_primary_10_1002_mog2_60 crossref_primary_10_1136_jitc_2023_008191 crossref_primary_10_3389_fimmu_2023_1076587 crossref_primary_10_3389_fonc_2022_1091088 crossref_primary_10_1042_BSR20221271 |
Cites_doi | 10.1186/s12964-019-0471-y 10.1002/hep.23054 10.1016/j.jhep.2014.08.023 10.7150/jca.42953 10.1371/journal.pbio.1000097 10.1002/hep.30166 10.1158/1078-0432.CCR-17-0741 10.1158/2326-6066.CIR-16-0297 10.1016/j.jhep.2015.06.001 10.1038/bjc.2013.32 10.1016/j.jhep.2018.10.040 10.1080/2162402X.2016.1234565 10.1038/s41467-020-16596-9 10.1038/s41467-018-07505-2 10.1111/imr.12527 10.1007/s00262-012-1294-5 10.1182/blood.V80.8.2012.2012 10.1016/j.bmcl.2019.126899 10.1007/s00262-019-02414-9 10.1002/cam4.3135 10.4049/jimmunol.170.6.3233 10.1158/1078-0432.CCR-16-1784 10.1101/gad.14.2.163 10.1056/NEJMoa0708857 10.1111/cei.12917 10.1016/j.immuni.2010.11.011 10.1038/s41420-020-0255-6 10.1038/s41467-017-00530-7 10.3389/fimmu.2019.02657 10.1002/jcb.25124 10.1053/j.gastro.2015.02.055 10.3892/mco.2017.1416 10.1016/j.jhep.2016.02.043 10.1158/0008-5472.CAN-17-0348 10.4049/jimmunol.180.9.5771 10.1158/0008-5472.CAN-11-4032 10.1016/j.jhep.2010.08.041 10.1371/journal.pone.0203228 10.1189/jlb.0411193 10.1080/2162402X.2016.1232221 10.4049/jimmunol.168.2.689 10.1002/ijc.31216 10.7314/APJCP.2014.15.6.2651 10.1158/1078-0432.CCR-17-3726 10.1002/cncr.26511 10.1016/j.ccr.2009.06.017 10.1038/nature14407 10.1111/imm.12906 10.1186/s12957-020-01953-1 10.1007/s00432-009-0634-0 10.1111/j.1440-1746.2004.03575.x 10.1200/JCO.2011.41.2395 10.1073/pnas.2015433118 10.1002/hep.23099 10.1016/j.smim.2017.12.004 10.1186/s13046-015-0256-0 10.1016/j.it.2016.03.006 10.1111/j.1600-065X.2009.00767.x 10.1038/nri1668 10.1038/sj.neo.7900110 10.1111/ctr.13743 10.1038/s41590-019-0571-2 10.1158/2326-6066.CIR-17-0204 10.1038/s41467-021-22973-9 10.14309/ctg.0000000000000056 10.1371/journal.pone.0031524 10.1002/jcla.22872 10.1016/j.ccell.2016.04.014 10.1002/pros.21495 10.1016/j.canlet.2015.02.036 10.1128/MCB.18.7.4301 10.1038/s41586-019-1118-2 10.1016/j.celrep.2017.10.104 10.1371/journal.pone.0079857 10.1177/039463201402700411 10.1186/s13046-015-0247-1 10.1002/ijc.25892 10.1038/s41575-018-0033-6 10.1172/JCI61067 10.1158/0008-5472.CAN-10-2583 10.3390/ijms18071414 10.1097/MD.0000000000002722 10.1002/cam4.3406 10.1111/liv.12688 10.1200/JCO.19.01307 10.3389/fimmu.2019.02243 10.3389/fimmu.2019.01419 10.1080/08820139.2017.1407787 10.1002/hep.32023 10.18632/oncotarget.6839 10.4049/jimmunol.170.2.1027 10.1002/path.2947 10.1016/j.celrep.2018.05.082 10.1038/sj.bjp.0703452 10.3349/ymj.2016.57.5.1115 10.1002/hep.30676 10.1016/j.jhep.2021.07.032 10.1186/s13058-019-1237-6 10.1038/s41388-018-0126-2 10.1002/bjs.10123 10.1097/MD.0000000000020919 10.1073/pnas.2013644117 10.1155/2017/7989020 10.1016/S0140-6736(17)31046-2 10.3390/ijms19061803 10.1038/s41575-020-0304-x 10.1080/2162402X.2016.1219828 10.1097/MEG.0b013e32835c2af3 10.1056/NEJMra1713263 10.1038/s41598-017-12968-2 10.1097/JTO.0b013e31805fea64 10.1038/nrd893 10.1038/nrclinonc.2016.217 10.1016/j.immuni.2014.03.013 10.1002/hep.27665 10.1016/j.intimp.2011.01.007 10.1038/s41423-020-00560-0 10.1002/hep.28655 10.1016/j.cell.2020.09.058 10.3389/fimmu.2018.01310 10.1016/j.jhep.2010.07.044 10.1016/j.jhep.2015.03.024 10.1038/s41568-020-0281-y 10.1172/jci.insight.130850 10.18632/aging.203162 10.3322/caac.21660 10.1158/2159-8290.CD-20-0304 10.1053/j.gastro.2016.02.040 10.1186/1478-811X-10-40 10.1002/hep.30630 10.1002/hep.25907 10.1200/JCO.2021.39.3_suppl.267 10.1016/j.bbrc.2017.02.128 10.1007/s00330-020-06931-5 10.18632/oncotarget.5578 10.1016/j.radonc.2015.04.006 10.4049/jimmunol.172.2.989 10.1080/2162402X.2015.1067744 10.3389/fimmu.2019.01912 10.1016/j.semcancer.2012.12.002 10.1182/blood-2006-11-010389 10.3389/fimmu.2019.03130 10.18632/oncotarget.2749 10.1038/s41572-020-00240-3 10.3390/ijms20205079 10.1038/s41590-018-0044-z 10.1038/s41571-019-0222-4 10.1016/j.jhep.2016.12.011 10.1038/s41416-018-0198-3 10.1186/s12885-016-2481-0 10.1002/ijc.31808 10.1172/JCI108517 10.1038/s41467-021-23667-y 10.1111/hepr.12167 10.1158/1078-0432.CCR-20-0414 10.1089/ars.2014.6108 10.1111/hepr.12019 10.1038/sj.bjc.6602702 10.1038/bjc.2016.23 10.3389/fonc.2020.01696 10.1073/pnas.1424927112 10.1038/nri2506 10.1002/path.4555 10.1161/01.RES.0000103311.52853.48 10.1016/j.jhep.2020.05.004 10.1186/s13045-019-0836-0 10.1056/NEJMoa1915745 10.1073/pnas.1613187113 10.1016/j.celrep.2014.12.039 10.18632/aging.102665 10.1002/hep.27859 10.1016/j.immuni.2019.03.024 10.3389/fonc.2020.00004 10.1186/s12885-019-5471-1 10.1016/j.immuni.2020.03.001 10.1002/hep.27070 10.1016/S0168-8278(01)00276-8 10.3389/fonc.2019.00664 10.1186/s12885-019-5740-z 10.1016/j.yexcr.2017.01.008 10.3389/fimmu.2012.00263 10.3389/fphys.2018.00113 10.18632/oncotarget.7680 10.1016/j.ymthe.2017.07.018 10.1158/0008-5472.CAN-17-3614 10.3389/fimmu.2018.01298 10.1200/JCO.2008.18.9498 10.1126/science.aay9189 10.1172/JCI74056 10.1038/s41591-018-0104-9 10.1038/bjc.2017.386 10.1007/s10637-018-0636-3 10.1002/ijc.28770 10.15252/embj.2020106048 10.1158/2326-6066.CIR-14-0036 10.1038/s41467-020-18125-0 10.1007/s004010051093 10.2353/ajpath.2010.090527 10.1371/journal.pone.0033655 10.1172/JCI41649 10.1016/j.ccell.2016.06.001 10.1002/jgm.3155 10.1038/ncomms7818 10.12659/MSM.918824 10.1189/jlb.0407247 10.1038/s41419-018-0458-4 10.1158/0008-5472.CAN-04-4505 10.2147/CMAR.S257934 10.4049/jimmunol.182.1.240 10.1136/gutjnl-2017-314032 10.1172/JCI66024 10.1038/s41423-020-0412-0 10.1136/bmjopen-2014-006404 10.1111/hepr.12436 10.1016/j.jhep.2013.08.011 10.18632/oncotarget.15456 10.1016/j.cell.2020.10.003 10.1172/JCI77053 10.1038/srep22089 10.1016/j.jhep.2018.06.009 10.1002/hep.29914 10.1038/s41577-021-00571-6 10.4049/jimmunol.120.4.1240 10.1101/2020.12.22.423933 |
ContentType | Journal Article |
Copyright | Springer Nature Limited 2022 2022. Springer Nature Limited. Springer Nature Limited 2022. |
Copyright_xml | – notice: Springer Nature Limited 2022 – notice: 2022. Springer Nature Limited. – notice: Springer Nature Limited 2022. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1038/s41575-021-00568-5 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Central Student MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1759-5053 |
EndPage | 273 |
ExternalDocumentID | 10_1038_s41575_021_00568_5 35022608 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GrantInformation_xml | – fundername: Cancer Research UK grantid: 26813 – fundername: Cancer Research UK grantid: 23390 – fundername: Medical Research Council grantid: MR/R023026/1 – fundername: Cancer Research UK grantid: C18342/A23390 – fundername: Cancer Research UK grantid: 29827 – fundername: Medical Research Council grantid: MR/K0019494/1 – fundername: Wellcome Trust grantid: WT107492Z |
GroupedDBID | --- 0R~ 29M 39C 3V. 53G 70F 7X7 88E 8FE 8FH 8FI 8FJ AAEEF AAQQT AARCD AASDW AAWTL AAWYQ AAZLF ABAWZ ABJNI ABLJU ABUWG ABVXF ACGFS ADBBV AENEX AFKRA AFSHS AGAYW AGEZK AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB AXYYD BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU DB5 EBS EE. EJD EXGXG F5P FQGFK FSGXE FYUFA HCIFZ HMCUK HZ~ IAO IHR IHW INH INR ITC LK8 M1P M7P NNMJJ ODYON OVD PQQKQ PROAC PSQYO RNR RNT RNTTT SHXYY SIXXV SNYQT TAOOD TBHMF TDRGL TEORI TSG UKHRP AAYZH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7XB 8FK AZQEC DWQXO GNUQQ K9. PQEST PQUKI PRINS 7X8 AAEXX ABEEJ ADZGE |
ID | FETCH-LOGICAL-c419t-50b72cf14195c136bcc73489b924fa22e3a97f8f5070f5d2bb154afd61ac00943 |
IEDL.DBID | BENPR |
ISSN | 1759-5045 |
IngestDate | Fri Aug 16 05:45:49 EDT 2024 Thu Oct 10 16:49:03 EDT 2024 Thu Sep 26 16:03:35 EDT 2024 Fri Oct 18 08:38:49 EDT 2024 Fri Oct 11 20:48:54 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | 2022. Springer Nature Limited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c419t-50b72cf14195c136bcc73489b924fa22e3a97f8f5070f5d2bb154afd61ac00943 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ORCID | 0000-0003-0950-243X 0000-0002-3592-7469 0000-0003-0359-9795 |
OpenAccessLink | https://www.pure.ed.ac.uk/ws/files/245822684/Mann_V2_edited_CLEAN_1633620070_1_DG.DAM.DG_tb.docx |
PMID | 35022608 |
PQID | 2645769230 |
PQPubID | 2042741 |
PageCount | 17 |
ParticipantIDs | proquest_miscellaneous_2619542095 proquest_journals_2645769230 crossref_primary_10_1038_s41575_021_00568_5 pubmed_primary_35022608 springer_journals_10_1038_s41575_021_00568_5 |
PublicationCentury | 2000 |
PublicationDate | 2022-04-01 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature reviews. Gastroenterology & hepatology |
PublicationTitleAbbrev | Nat Rev Gastroenterol Hepatol |
PublicationTitleAlternate | Nat Rev Gastroenterol Hepatol |
PublicationYear | 2022 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Reebye (CR188) 2018; 37 Condamine (CR211) 2014; 124 Li (CR84) 2015; 34 Mackey, Coffelt, Carlin (CR51) 2019; 10 Li (CR59) 2017; 8 Gabrilovich, Nagaraj (CR46) 2009; 9 Ballesteros (CR13) 2020; 183 Wang (CR146) 2016; 6 Steele (CR170) 2016; 29 Eruslanov (CR26) 2014; 124 Connor (CR226) 2018; 69 Zea (CR49) 2005; 65 Finn (CR15) 2020; 382 Zhou, Nefedova, Lei, Gabrilovich (CR178) 2018; 35 Zhou (CR91) 2012; 56 Matlung, Szilagyi, Barclay, van den Berg (CR205) 2017; 276 Lacotte (CR136) 2016; 5 Ikeda (CR183) 2019; 37 Song (CR89) 2020; 18 Jensen (CR96) 2009; 27 Elwan (CR126) 2018; 47 Guo (CR56) 2020; 12 Yuan (CR68) 2017; 7 Colotta, Re, Polentarutti, Sozzani, Mantovani (CR12) 1992; 80 Gabrilovich (CR45) 2017; 5 Jaillon (CR238) 2020; 20 Pulli (CR231) 2015; 23 Hu (CR57) 2016; 57 Couper, Blount, Riley (CR143) 2008; 180 Jamieson (CR169) 2012; 122 CR171 Rosales (CR8) 2018; 9 Lang (CR47) 2018; 24 Torrens (CR162) 2021; 74 Finisguerra (CR156) 2015; 522 Sagiv (CR33) 2015; 10 Vellenga, Dokter, Halie (CR194) 1993; 7 Adrover (CR54) 2020; 21 Hsieh, Hung, Chiang, Tsai, He (CR122) 2019; 20 Taïeb (CR233) 2002; 36 Jensen (CR97) 2012; 118 Sung (CR1) 2021; 71 Dancey, Deubelbeiss, Harker, Finch (CR11) 1976; 58 Xu (CR172) 2014; 27 Kalafati (CR154) 2020; 183 Li, Han, Guo, Zhang, Cao (CR137) 2009; 182 Tian, Lyu, Yang, Hu (CR227) 2020; 10 Skelton, Ortega-Prieto, Dorner (CR228) 2018; 154 Liu (CR48) 2010; 136 Dyson (CR100) 2014; 60 Liao (CR118) 2021; 13 Chen (CR175) 2015; 61 Peng, Wang, Liu, Ma (CR77) 2015; 8 Schiffmann (CR161) 2019; 120 Zhou (CR113) 2019; 70 Teijeira (CR148) 2020; 52 Shen, Wang, He, Wang, Zheng (CR127) 2014; 44 Li (CR7) 2019; 17 Zhang (CR237) 2021; 11 Munder (CR32) 2006; 108 Llovet (CR3) 2021; 7 Biyik (CR71) 2013; 25 Yu (CR139) 2019; 70 Wang (CR114) 2018; 9 Shrestha (CR222) 2016; 5 Wu (CR93) 2011; 225 Yamashita, Wang (CR145) 2013; 123 Lee (CR190) 2015; 148 CR240 Ramachandran, Matchett, Dobie, Wilson-Kanamori, Henderson (CR41) 2020; 17 El-Khoueiry (CR16) 2017; 389 Harty (CR232) 2010; 176 CR239 Nejman (CR236) 2020; 368 Wang (CR131) 2021; 75 Song (CR176) 2021; 118 Liu (CR88) 2020; 12 Cheng (CR214) 2015; 63 Riley (CR140) 2009; 229 Németh (CR117) 2009; 50 Zhao (CR181) 2015; 6 Villanueva (CR2) 2019; 380 Thorburn (CR210) 2007; 2 Finn (CR18) 2021; 39 CR241 CR242 Shen (CR217) 2015; 3 Yeo (CR198) 2012; 30 Huang (CR120) 2019; 10 Renshaw (CR213) 2003; 170 Xu (CR107) 2019; 68 Dharmapuri (CR70) 2020; 9 Singhal (CR157) 2016; 30 Yang (CR150) 2020; 13 Yoon (CR191) 2019; 19 Fossati (CR94) 1999; 98 Liu (CR111) 2015; 6 Deronic, Tahvili, Leanderson, Ivars (CR219) 2016; 16 Li (CR86) 2011; 54 Lu (CR61) 2016; 95 Brown, Heinrich, Greten (CR225) 2018; 15 Sody (CR224) 2019; 10 Björk (CR216) 2009; 7 Wiechert (CR116) 2012; 10 Li (CR110) 2019; 70 Li, Xu, Deng, Wang, Jia (CR73) 2020; 99 Steele (CR168) 2015; 237 Wu (CR67) 2018; 40 Stadtmann, Zarbock (CR165) 2012; 3 Borregaard (CR6) 2010; 33 Zhao (CR99) 2012; 7 Bronte, Zanovello (CR141) 2005; 5 van Egmond, Bakema (CR158) 2013; 23 CR101 Lagnado (CR129) 2021; 40 Margetts (CR62) 2018; 118 Brostjan, Oehler (CR10) 2020; 6 Schmidt (CR78) 2005; 93 Peddibhotla (CR173) 2020; 30 Zhou (CR37) 2016; 150 Markowitz, Carson (CR215) 2013; 1835 Hu, Lou, Ye, Zhang (CR81) 2015; 5 Fan (CR180) 2019; 19 Jalil, Andrechak, Discher (CR209) 2020; 3 Ringelhan, Pfister, O’Connor, Pikarsky, Heikenwalder (CR5) 2018; 19 Liu, Wang, Xu (CR9) 2021; 18 Gregory, Houghton (CR151) 2011; 71 Wilson (CR115) 2015; 6 Dumitru, Fechner, Hoffmann, Lang, Brandau (CR25) 2012; 91 Trellakis (CR98) 2011; 129 van der Windt (CR130) 2018; 68 Lin (CR76) 2016; 7 Sun (CR80) 2016; 9 Biasci (CR177) 2020; 117 Friedman, Neuschwander-Tetri, Rinella, Sanyal (CR230) 2018; 24 Schoof (CR43) 2021; 12 Rotella (CR193) 2002; 1 Radomska (CR185) 1998; 18 Gao (CR83) 2012; 72 Ogura (CR235) 2018; 6 CR203 CR204 CR42 Matlung (CR159) 2018; 23 Wang (CR90) 2019; 33 CR202 Carvalho, Aquino, Neves, Fontes (CR19) 2015; 116 Haqqani, Sandhu, Birnboim (CR28) 2000; 2 Kusmartsev, Nefedova, Yoder, Gabrilovich (CR40) 2004; 172 Gu (CR75) 2016; 6 Kong (CR58) 2020; 26 Okamura (CR64) 2016; 103 Haider (CR109) 2019; 69 Mantovani, Marchesi, Malesci, Laghi, Allavena (CR22) 2017; 14 Kemal (CR79) 2014; 15 Dominguez (CR212) 2017; 23 Fridlender (CR23) 2009; 16 Orillion (CR200) 2017; 23 Feng (CR149) 2013; 8 Wang (CR66) 2020; 11 Jennbacken (CR218) 2012; 72 Terashima (CR69) 2015; 45 CR53 Mishalian (CR31) 2014; 135 Voutila (CR186) 2017; 25 Cheng (CR104) 2018; 9 Chen (CR164) 2020; 10 Liu, Shen, Lu (CR179) 2017; 486 Fransén Pettersson (CR220) 2018; 13 Fridlender (CR27) 2012; 7 Su, Banerjee, White, Kortylewski (CR201) 2018; 19 Mazzoni (CR142) 2002; 168 Blattner (CR24) 2018; 78 Stackowicz, Jönsson, Reber (CR229) 2019; 10 Chiu (CR121) 2017; 8 Weber (CR167) 2018; 9 Takeshima (CR38) 2016; 113 Ryckman, Vandal, Rouleau, Talbot, Tessier (CR119) 2003; 170 Mohs (CR106) 2017; 66 Snoderly, Boone, Bennewitz (CR243) 2019; 21 Eckschlager, Plch, Stiborova, Hrabeta (CR199) 2017; 18 Schobert (CR65) 2020; 30 Xiao (CR208) 2015; 360 McVey (CR63) 2019; 33 Xu (CR123) 2017; 351 Chee, Townsend, Galbraith, Eilber, Morton (CR152) 1978; 38 Leithead, Rajoriya, Gunson, Ferguson (CR72) 2015; 35 Shaul, Fridlender (CR14) 2019; 16 Veglia (CR50) 2019; 569 Yu, Stamenkovic (CR147) 2000; 14 Dumitru, Moses, Trellakis, Lang, Brandau (CR21) 2012; 61 Yan, Huo, Wang, Feng, Gong (CR132) 2015; 63 Shaul (CR34) 2016; 5 Chang (CR133) 2018; 142 Webb, Hirst, Giembycz (CR195) 2000; 130 Li (CR234) 2020; 11 Ino (CR95) 2013; 108 Pylaeva (CR221) 2019; 144 Rice (CR39) 2018; 9 Chen, Chen, Li, Ren (CR82) 2020; 22 Mackert (CR187) 2017; 7 Dvorak, Connell, Proppe, Dvorak (CR153) 1978; 120 CR4 Limaye (CR60) 2013; 43 Baharlou, Canete, Cunningham, Harman, Patrick (CR44) 2019; 10 Pilz, Casteel (CR192) 2003; 93 Lo (CR207) 2015; 62 Kuang (CR30) 2011; 54 Bitzer (CR197) 2016; 65 Imai (CR135) 2005; 20 Kelley (CR184) 2019; 10 He (CR29) 2015; 34 Xu (CR124) 2016; 7 Sarker (CR189) 2020; 26 Boivin (CR223) 2020; 11 Toor, Elkord (CR35) 2017; 2017 Hawila (CR174) 2017; 21 Grenader (CR74) 2016; 114 Nourshargh, Renshaw, Imhof (CR128) 2016; 37 Li, Xu, Han, Yuan, Wu (CR85) 2019; 9 Metzemaekers, Gouwy, Proost (CR103) 2020; 17 Hoechst (CR134) 2009; 50 Zhang (CR108) 2017; 188 Zhou (CR125) 2018; 67 Llovet (CR160) 2008; 359 CR196 Daley, Thomay, Connolly, Reichner, Albina (CR20) 2008; 83 Grieshaber-Bouyer (CR55) 2021; 12 Gershkovitz (CR155) 2018; 78 Lee (CR206) 2014; 60 He (CR92) 2016; 5 Huertas (CR163) 2015; 115 Casbon (CR52) 2015; 112 Liu, Wu, Qi, Qin, Zhu (CR87) 2020; 9 Chiu (CR105) 2016; 64 Peng (CR112) 2020; 73 Kargl (CR166) 2019; 24 Zhou (CR182) 2011; 11 Batlle, Massagué (CR144) 2019; 50 Wu (CR36) 2014; 40 Finn (CR17) 2020; 38 Eash, Greenbaum, Gopalan, Link (CR102) 2010; 120 Li (CR138) 2015; 62 J Stackowicz (568_CR229) 2019; 10 I Mishalian (568_CR31) 2014; 135 H Schmidt (568_CR78) 2005; 93 C Yan (568_CR132) 2015; 63 568_CR4 J Dyson (568_CR100) 2014; 60 M Xu (568_CR123) 2017; 351 X Gu (568_CR75) 2016; 6 J Voutila (568_CR186) 2017; 25 TK Lee (568_CR206) 2014; 60 A-J Casbon (568_CR52) 2015; 112 P Wu (568_CR36) 2014; 40 D Nejman (568_CR236) 2020; 368 J Zhou (568_CR125) 2018; 67 CC Hsieh (568_CR122) 2019; 20 J-S Song (568_CR176) 2021; 118 ZJ Brown (568_CR225) 2018; 15 Y Wang (568_CR90) 2019; 33 M Huang (568_CR120) 2019; 10 Q Yu (568_CR147) 2000; 14 HS Radomska (568_CR185) 1998; 18 A Mohs (568_CR106) 2017; 66 ZG Fridlender (568_CR23) 2009; 16 S Lang (568_CR47) 2018; 24 K Jennbacken (568_CR218) 2012; 72 AL Cheng (568_CR214) 2015; 63 L Torrens (568_CR162) 2021; 74 J Kargl (568_CR166) 2019; 24 H Zhang (568_CR108) 2017; 188 J Markowitz (568_CR215) 2013; 1835 M Ringelhan (568_CR5) 2018; 19 Y Li (568_CR7) 2019; 17 Y Imai (568_CR135) 2005; 20 W Kong (568_CR58) 2020; 26 S Peddibhotla (568_CR173) 2020; 30 E Batlle (568_CR144) 2019; 50 TO Jensen (568_CR97) 2012; 118 568_CR196 K Ogura (568_CR235) 2018; 6 SL Friedman (568_CR230) 2018; 24 T Jamieson (568_CR169) 2012; 122 HL Sun (568_CR80) 2016; 9 RS Finn (568_CR17) 2020; 38 C Ryckman (568_CR119) 2003; 170 RB Pilz (568_CR192) 2003; 93 D Sarker (568_CR189) 2020; 26 Á Teijeira (568_CR148) 2020; 52 Y Wang (568_CR66) 2020; 11 H Tian (568_CR227) 2020; 10 J Liao (568_CR118) 2021; 13 JC McVey (568_CR63) 2019; 33 Y Liu (568_CR88) 2020; 12 IT Schobert (568_CR65) 2020; 30 A Orillion (568_CR200) 2017; 23 T Grenader (568_CR74) 2016; 114 S Shrestha (568_CR222) 2016; 5 HL Matlung (568_CR205) 2017; 276 V Reebye (568_CR188) 2018; 37 AR Limaye (568_CR60) 2013; 43 CA Dumitru (568_CR25) 2012; 91 SL Zhou (568_CR37) 2016; 150 568_CR171 JY Sagiv (568_CR33) 2015; 10 W Li (568_CR85) 2019; 9 J Zhou (568_CR182) 2011; 11 P Li (568_CR234) 2020; 11 P Ramachandran (568_CR41) 2020; 17 T Terashima (568_CR69) 2015; 45 J Zhou (568_CR178) 2018; 35 M Ikeda (568_CR183) 2019; 37 JT Dancey (568_CR11) 1976; 58 SL Zhou (568_CR91) 2012; 56 J Chen (568_CR164) 2020; 10 L Kalafati (568_CR154) 2020; 183 Q Gao (568_CR83) 2012; 72 Y Fan (568_CR180) 2019; 19 B Pulli (568_CR231) 2015; 23 SA Renshaw (568_CR213) 2003; 170 T Condamine (568_CR211) 2014; 124 E Hawila (568_CR174) 2017; 21 A Mantovani (568_CR22) 2017; 14 C Blattner (568_CR24) 2018; 78 LM Schiffmann (568_CR161) 2019; 120 AB El-Khoueiry (568_CR16) 2017; 389 R Weber (568_CR167) 2018; 9 S Singhal (568_CR157) 2016; 30 M He (568_CR92) 2016; 5 X Li (568_CR59) 2017; 8 ZG Fridlender (568_CR27) 2012; 7 T Takeshima (568_CR38) 2016; 113 HT Snoderly (568_CR243) 2019; 21 EM Schoof (568_CR43) 2021; 12 RK Kelley (568_CR184) 2019; 10 JM Adrover (568_CR54) 2020; 21 M van Egmond (568_CR158) 2013; 23 XG Hu (568_CR57) 2016; 57 W Chen (568_CR82) 2020; 22 Y Ino (568_CR95) 2013; 108 YW Li (568_CR86) 2011; 54 I Ballesteros (568_CR13) 2020; 183 P Shen (568_CR127) 2014; 44 J Margetts (568_CR62) 2018; 118 S Kusmartsev (568_CR40) 2004; 172 WR Liu (568_CR111) 2015; 6 BL Webb (568_CR195) 2000; 130 AR Jalil (568_CR209) 2020; 3 E Pylaeva (568_CR221) 2019; 144 L Wiechert (568_CR116) 2012; 10 JJ Zhao (568_CR99) 2012; 7 ME Shaul (568_CR34) 2016; 5 S Jaillon (568_CR238) 2020; 20 M Gershkovitz (568_CR155) 2018; 78 A Lagnado (568_CR129) 2021; 40 RS Finn (568_CR18) 2021; 39 DI Gabrilovich (568_CR45) 2017; 5 JM Llovet (568_CR160) 2008; 359 H Liu (568_CR179) 2017; 486 MW Harty (568_CR232) 2010; 176 HK Jensen (568_CR96) 2009; 27 M Metzemaekers (568_CR103) 2020; 17 A Huertas (568_CR163) 2015; 115 A Thorburn (568_CR210) 2007; 2 XX Feng (568_CR149) 2013; 8 CQ Wang (568_CR146) 2016; 6 XL Wu (568_CR67) 2018; 40 568_CR242 568_CR241 Y Wu (568_CR93) 2011; 225 H Sung (568_CR1) 2021; 71 S Nourshargh (568_CR128) 2016; 37 HL Matlung (568_CR159) 2018; 23 N Borregaard (568_CR6) 2010; 33 568_CR240 JK Skelton (568_CR228) 2018; 154 T Liu (568_CR87) 2020; 9 B Hoechst (568_CR134) 2009; 50 568_CR239 SL Zhou (568_CR113) 2019; 70 XF Li (568_CR138) 2015; 62 K Liu (568_CR9) 2021; 18 S Trellakis (568_CR98) 2011; 129 Y Okamura (568_CR64) 2016; 103 A Villanueva (568_CR2) 2019; 380 JM Llovet (568_CR3) 2021; 7 K Hu (568_CR81) 2015; 5 LO Carvalho (568_CR19) 2015; 116 AS Haqqani (568_CR28) 2000; 2 EB Eruslanov (568_CR26) 2014; 124 J Taïeb (568_CR233) 2002; 36 M Bitzer (568_CR197) 2016; 65 CL Wilson (568_CR115) 2015; 6 P Björk (568_CR216) 2009; 7 RS Finn (568_CR15) 2020; 382 CY Liu (568_CR48) 2010; 136 DP Rotella (568_CR193) 2002; 1 Z Xiao (568_CR208) 2015; 360 S Dharmapuri (568_CR70) 2020; 9 JA Leithead (568_CR72) 2015; 35 A Mazzoni (568_CR142) 2002; 168 L Guo (568_CR56) 2020; 12 568_CR101 E Vellenga (568_CR194) 1993; 7 H Baharlou (568_CR44) 2019; 10 SD Lu (568_CR61) 2016; 95 Y Xu (568_CR107) 2019; 68 H Wang (568_CR131) 2021; 75 KN Couper (568_CR143) 2008; 180 G He (568_CR29) 2015; 34 DM Kuang (568_CR30) 2011; 54 LY Yang (568_CR150) 2020; 13 CW Steele (568_CR168) 2015; 237 C Rosales (568_CR8) 2018; 9 JBG Mackey (568_CR51) 2019; 10 Y Cheng (568_CR104) 2018; 9 Q Zhang (568_CR237) 2021; 11 Y Chen (568_CR175) 2015; 61 G Boivin (568_CR223) 2020; 11 ME Shaul (568_CR14) 2019; 16 A Stadtmann (568_CR165) 2012; 3 L Li (568_CR84) 2015; 34 CJ Chang (568_CR133) 2018; 142 R Grieshaber-Bouyer (568_CR55) 2021; 12 M Biyik (568_CR71) 2013; 25 V Finisguerra (568_CR156) 2015; 522 F Connor (568_CR226) 2018; 69 YM Li (568_CR110) 2019; 70 V Bronte (568_CR141) 2005; 5 DO Chee (568_CR152) 1978; 38 T Yamashita (568_CR145) 2013; 123 D Biasci (568_CR177) 2020; 117 568_CR202 568_CR204 568_CR203 SJ Yu (568_CR139) 2019; 70 N Fransén Pettersson (568_CR220) 2018; 13 DK Chiu (568_CR105) 2016; 64 568_CR42 H Li (568_CR137) 2009; 182 SC Li (568_CR73) 2020; 99 JL Riley (568_CR140) 2009; 229 DK Chiu (568_CR121) 2017; 8 L Shen (568_CR217) 2015; 3 CA Dumitru (568_CR21) 2012; 61 M Munder (568_CR32) 2006; 108 D Song (568_CR89) 2020; 18 W Yeo (568_CR198) 2012; 30 JR Mackert (568_CR187) 2017; 7 SM Toor (568_CR35) 2017; 2017 CM Rice (568_CR39) 2018; 9 F Veglia (568_CR50) 2019; 569 568_CR53 J Lo (568_CR207) 2015; 62 G Fossati (568_CR94) 1999; 98 C Haider (568_CR109) 2019; 69 H Zhao (568_CR181) 2015; 6 Y Kemal (568_CR79) 2014; 15 J Yuan (568_CR68) 2017; 7 C Brostjan (568_CR10) 2020; 6 S Wang (568_CR114) 2018; 9 S Sody (568_CR224) 2019; 10 JM Daley (568_CR20) 2008; 83 YL Su (568_CR201) 2018; 19 A Deronic (568_CR219) 2016; 16 AH Zea (568_CR49) 2005; 65 ZP Peng (568_CR112) 2020; 73 T Eckschlager (568_CR199) 2017; 18 GA Dominguez (568_CR212) 2017; 23 AM Dvorak (568_CR153) 1978; 120 DI Gabrilovich (568_CR46) 2009; 9 J Németh (568_CR117) 2009; 50 G Lin (568_CR76) 2016; 7 N Elwan (568_CR126) 2018; 47 S Lacotte (568_CR136) 2016; 5 AD Gregory (568_CR151) 2011; 71 JM Xu (568_CR172) 2014; 27 JS Yoon (568_CR191) 2019; 19 DJ van der Windt (568_CR130) 2018; 68 F Colotta (568_CR12) 1992; 80 KJ Eash (568_CR102) 2010; 120 CW Steele (568_CR170) 2016; 29 B Peng (568_CR77) 2015; 8 JH Lee (568_CR190) 2015; 148 Y Xu (568_CR124) 2016; 7 |
References_xml | – volume: 17 start-page: 147 year: 2019 ident: CR7 article-title: The regulatory roles of neutrophils in adaptive immunity publication-title: Cell Commun. Signal. doi: 10.1186/s12964-019-0471-y contributor: fullname: Li – volume: 50 start-page: 799 year: 2009 end-page: 807 ident: CR134 article-title: Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor publication-title: Hepatology doi: 10.1002/hep.23054 contributor: fullname: Hoechst – ident: CR196 – volume: 62 start-page: 131 year: 2015 end-page: 139 ident: CR138 article-title: Increased autophagy sustains the survival and pro-tumorigenic effects of neutrophils in human hepatocellular carcinoma publication-title: J. Hepatol. doi: 10.1016/j.jhep.2014.08.023 contributor: fullname: Li – volume: 11 start-page: 3736 year: 2020 end-page: 3744 ident: CR66 article-title: Circulating neutrophils predict poor survival for HCC and promote HCC progression through p53 and STAT3 signaling pathway publication-title: J. Cancer doi: 10.7150/jca.42953 contributor: fullname: Wang – volume: 7 year: 2009 ident: CR216 article-title: Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides publication-title: PLoS Biol. doi: 10.1371/journal.pbio.1000097 contributor: fullname: Björk – volume: 69 start-page: 222 year: 2019 end-page: 236 ident: CR109 article-title: Transforming growth factor-β and Axl induce CXCL5 and neutrophil recruitment in hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.30166 contributor: fullname: Haider – volume: 23 start-page: 5187 year: 2017 end-page: 5201 ident: CR200 article-title: Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-0741 contributor: fullname: Orillion – volume: 5 start-page: 3 year: 2017 end-page: 8 ident: CR45 article-title: Myeloid-derived suppressor cells publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-16-0297 contributor: fullname: Gabrilovich – volume: 63 start-page: 896 year: 2015 end-page: 904 ident: CR214 article-title: Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: a phase 2 randomized study publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.06.001 contributor: fullname: Cheng – volume: 108 start-page: 914 year: 2013 end-page: 923 ident: CR95 article-title: Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer publication-title: Br. J. Cancer doi: 10.1038/bjc.2013.32 contributor: fullname: Ino – volume: 70 start-page: 449 year: 2019 end-page: 457 ident: CR139 article-title: Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.10.040 contributor: fullname: Yu – volume: 5 year: 2016 ident: CR136 article-title: Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1234565 contributor: fullname: Lacotte – volume: 11 start-page: 2762 year: 2020 ident: CR223 article-title: Durable and controlled depletion of neutrophils in mice publication-title: Nat. Commun. doi: 10.1038/s41467-020-16596-9 contributor: fullname: Boivin – volume: 9 year: 2018 ident: CR39 article-title: Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression publication-title: Nat. Commun. doi: 10.1038/s41467-018-07505-2 contributor: fullname: Rice – volume: 276 start-page: 145 year: 2017 end-page: 164 ident: CR205 article-title: The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer publication-title: Immunol. Rev. doi: 10.1111/imr.12527 contributor: fullname: van den Berg – volume: 61 start-page: 1155 year: 2012 end-page: 1167 ident: CR21 article-title: Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology publication-title: Cancer Immunol. Immunother. doi: 10.1007/s00262-012-1294-5 contributor: fullname: Brandau – volume: 80 start-page: 2012 year: 1992 end-page: 2020 ident: CR12 article-title: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products publication-title: Blood doi: 10.1182/blood.V80.8.2012.2012 contributor: fullname: Mantovani – volume: 30 start-page: 126899 year: 2020 ident: CR173 article-title: Discovery of small molecule antagonists of chemokine receptor CXCR6 that arrest tumor growth in SK-HEP-1 mouse xenografts as a model of hepatocellular carcinoma publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2019.126899 contributor: fullname: Peddibhotla – volume: 68 start-page: 1959 year: 2019 end-page: 1969 ident: CR107 article-title: Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma publication-title: Cancer Immunol. Immunother. doi: 10.1007/s00262-019-02414-9 contributor: fullname: Xu – ident: CR241 – volume: 9 start-page: 4962 year: 2020 end-page: 4970 ident: CR70 article-title: Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti-PD-1 therapy publication-title: Cancer Med. doi: 10.1002/cam4.3135 contributor: fullname: Dharmapuri – volume: 170 start-page: 3233 year: 2003 end-page: 3242 ident: CR119 article-title: Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion publication-title: J. Immunol. doi: 10.4049/jimmunol.170.6.3233 contributor: fullname: Tessier – ident: CR242 – volume: 23 start-page: 2942 year: 2017 end-page: 2950 ident: CR212 article-title: Selective targeting of myeloid-derived suppressor cells in cancer patients using DS-8273a, an agonistic TRAIL-R2 antibody publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-16-1784 contributor: fullname: Dominguez – volume: 14 start-page: 163 year: 2000 end-page: 176 ident: CR147 article-title: Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis publication-title: Genes Dev. doi: 10.1101/gad.14.2.163 contributor: fullname: Stamenkovic – volume: 359 start-page: 378 year: 2008 end-page: 390 ident: CR160 article-title: Sorafenib in advanced hepatocellular carcinoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0708857 contributor: fullname: Llovet – volume: 188 start-page: 96 year: 2017 end-page: 108 ident: CR108 article-title: Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver publication-title: Clin. Exp. Immunol. doi: 10.1111/cei.12917 contributor: fullname: Zhang – volume: 33 start-page: 657 year: 2010 end-page: 670 ident: CR6 article-title: Neutrophils, from marrow to microbes publication-title: Immunity doi: 10.1016/j.immuni.2010.11.011 contributor: fullname: Borregaard – volume: 6 start-page: 26 year: 2020 ident: CR10 article-title: The role of neutrophil death in chronic inflammation and cancer publication-title: Cell Death Discov. doi: 10.1038/s41420-020-0255-6 contributor: fullname: Oehler – volume: 8 year: 2017 ident: CR121 article-title: Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma publication-title: Nat. Commun. doi: 10.1038/s41467-017-00530-7 contributor: fullname: Chiu – volume: 10 start-page: 2657 year: 2019 ident: CR44 article-title: Mass cytometry imaging for the study of human diseases-applications and data analysis strategies publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02657 contributor: fullname: Patrick – volume: 116 start-page: 1831 year: 2015 end-page: 1836 ident: CR19 article-title: The neutrophil nucleus and its role in neutrophilic function publication-title: J. Cell Biochem. doi: 10.1002/jcb.25124 contributor: fullname: Fontes – volume: 148 start-page: 1383 year: 2015 end-page: 1391.e1386 ident: CR190 article-title: Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.02.055 contributor: fullname: Lee – volume: 7 start-page: 837 year: 2017 end-page: 842 ident: CR68 article-title: Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib publication-title: Mol. Clin. Oncol. doi: 10.3892/mco.2017.1416 contributor: fullname: Yuan – volume: 65 start-page: 280 year: 2016 end-page: 288 ident: CR197 article-title: Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma — the SHELTER study publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.02.043 contributor: fullname: Bitzer – volume: 78 start-page: 157 year: 2018 end-page: 167 ident: CR24 article-title: CCR5 myeloid-derived suppressor cells are enriched and activated in melanoma lesions publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-17-0348 contributor: fullname: Blattner – volume: 180 start-page: 5771 year: 2008 end-page: 5777 ident: CR143 article-title: IL-10: the master regulator of immunity to infection publication-title: J. Immunol. doi: 10.4049/jimmunol.180.9.5771 contributor: fullname: Riley – volume: 72 start-page: 3546 year: 2012 end-page: 3556 ident: CR83 article-title: CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-11-4032 contributor: fullname: Gao – volume: 54 start-page: 948 year: 2011 end-page: 955 ident: CR30 article-title: Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma publication-title: J. Hepatol. doi: 10.1016/j.jhep.2010.08.041 contributor: fullname: Kuang – volume: 13 year: 2018 ident: CR220 article-title: The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis publication-title: PLoS ONE doi: 10.1371/journal.pone.0203228 contributor: fullname: Fransén Pettersson – volume: 91 start-page: 591 year: 2012 end-page: 598 ident: CR25 article-title: A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0411193 contributor: fullname: Brandau – volume: 5 year: 2016 ident: CR34 article-title: Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: a transcriptomics analysis of pro- vs. antitumor TANs publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1232221 contributor: fullname: Shaul – volume: 168 start-page: 689 year: 2002 end-page: 695 ident: CR142 article-title: Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism publication-title: J. Immunol. doi: 10.4049/jimmunol.168.2.689 contributor: fullname: Mazzoni – volume: 142 start-page: 1878 year: 2018 end-page: 1889 ident: CR133 article-title: Targeting tumor-infiltrating Ly6G myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma publication-title: Int. J. Cancer doi: 10.1002/ijc.31216 contributor: fullname: Chang – volume: 15 start-page: 2651 year: 2014 end-page: 2654 ident: CR79 article-title: Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis publication-title: Asian Pac. J. Cancer Prev. doi: 10.7314/APJCP.2014.15.6.2651 contributor: fullname: Kemal – volume: 24 start-page: 4834 year: 2018 end-page: 4844 ident: CR47 article-title: Clinical relevance and suppressive capacity of human myeloid-derived suppressor cell subsets publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-3726 contributor: fullname: Lang – ident: CR202 – volume: 118 start-page: 2476 year: 2012 end-page: 2485 ident: CR97 article-title: Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma publication-title: Cancer doi: 10.1002/cncr.26511 contributor: fullname: Jensen – volume: 16 start-page: 183 year: 2009 end-page: 194 ident: CR23 article-title: Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.06.017 contributor: fullname: Fridlender – volume: 522 start-page: 349 year: 2015 end-page: 353 ident: CR156 article-title: MET is required for the recruitment of anti-tumoural neutrophils publication-title: Nature doi: 10.1038/nature14407 contributor: fullname: Finisguerra – volume: 154 start-page: 50 year: 2018 end-page: 61 ident: CR228 article-title: A Hitchhiker’s guide to humanized mice: new pathways to studying viral infections publication-title: Immunology doi: 10.1111/imm.12906 contributor: fullname: Dorner – volume: 18 start-page: 176 year: 2020 ident: CR89 article-title: DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma publication-title: World J. Surg. Oncol. doi: 10.1186/s12957-020-01953-1 contributor: fullname: Song – volume: 136 start-page: 35 year: 2010 end-page: 45 ident: CR48 article-title: Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b /CD14 /CD15 /CD33 myeloid-derived suppressor cells and CD8 T lymphocytes in patients with advanced-stage non-small cell lung cancer publication-title: J. Cancer Res. Clin. Oncol. doi: 10.1007/s00432-009-0634-0 contributor: fullname: Liu – volume: 20 start-page: 287 year: 2005 end-page: 293 ident: CR135 article-title: Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: an in vitro study publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2004.03575.x contributor: fullname: Imai – volume: 30 start-page: 3361 year: 2012 end-page: 3367 ident: CR198 article-title: Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2011.41.2395 contributor: fullname: Yeo – volume: 118 year: 2021 ident: CR176 article-title: A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.2015433118 contributor: fullname: Song – volume: 50 start-page: 1251 year: 2009 end-page: 1262 ident: CR117 article-title: S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis publication-title: Hepatology doi: 10.1002/hep.23099 contributor: fullname: Németh – volume: 35 start-page: 19 year: 2018 end-page: 28 ident: CR178 article-title: Neutrophils and PMN-MDSC: their biological role and interaction with stromal cells publication-title: Semin. Immunol. doi: 10.1016/j.smim.2017.12.004 contributor: fullname: Gabrilovich – volume: 34 start-page: 141 year: 2015 ident: CR29 article-title: Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-015-0256-0 contributor: fullname: He – volume: 37 start-page: 273 year: 2016 end-page: 286 ident: CR128 article-title: Reverse migration of neutrophils: where, when, how, and why? publication-title: Trends Immunol. doi: 10.1016/j.it.2016.03.006 contributor: fullname: Imhof – volume: 229 start-page: 114 year: 2009 end-page: 125 ident: CR140 article-title: PD-1 signaling in primary T cells publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2009.00767.x contributor: fullname: Riley – volume: 5 start-page: 641 year: 2005 end-page: 654 ident: CR141 article-title: Regulation of immune responses by -arginine metabolism publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1668 contributor: fullname: Zanovello – volume: 2 start-page: 561 year: 2000 end-page: 568 ident: CR28 article-title: Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutatect tumors publication-title: Neoplasia doi: 10.1038/sj.neo.7900110 contributor: fullname: Birnboim – volume: 33 year: 2019 ident: CR63 article-title: Prognostication of inflammatory cells in liver transplantation: Is the waitlist neutrophil-to-lymphocyte ratio really predictive of tumor biology? publication-title: Clin. Transpl. doi: 10.1111/ctr.13743 contributor: fullname: McVey – volume: 21 start-page: 135 year: 2020 end-page: 144 ident: CR54 article-title: Programmed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation publication-title: Nat. Immunol. doi: 10.1038/s41590-019-0571-2 contributor: fullname: Adrover – volume: 6 start-page: 348 year: 2018 end-page: 357 ident: CR235 article-title: NK cells control tumor-promoting function of neutrophils in mice publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-17-0204 contributor: fullname: Ogura – volume: 12 year: 2021 ident: CR55 article-title: The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments publication-title: Nat. Commun. doi: 10.1038/s41467-021-22973-9 contributor: fullname: Grieshaber-Bouyer – volume: 10 year: 2019 ident: CR184 article-title: A phase 2 study of galunisertib (TGF-β1 receptor type i inhibitor) and sorafenib in patients with advanced hepatocellular carcinoma publication-title: Clin. Transl. Gastroenterol. doi: 10.14309/ctg.0000000000000056 contributor: fullname: Kelley – volume: 7 year: 2012 ident: CR27 article-title: Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils publication-title: PLoS ONE doi: 10.1371/journal.pone.0031524 contributor: fullname: Fridlender – volume: 33 year: 2019 ident: CR90 article-title: IDO and intra-tumoral neutrophils were independent prognostic factors for overall survival for hepatocellular carcinoma publication-title: J. Clin. Lab. Anal. doi: 10.1002/jcla.22872 contributor: fullname: Wang – volume: 29 start-page: 832 year: 2016 end-page: 845 ident: CR170 article-title: CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.04.014 contributor: fullname: Steele – volume: 72 start-page: 913 year: 2012 end-page: 924 ident: CR218 article-title: Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050) publication-title: Prostate doi: 10.1002/pros.21495 contributor: fullname: Jennbacken – volume: 360 start-page: 302 year: 2015 end-page: 309 ident: CR208 article-title: Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma publication-title: Cancer Lett. doi: 10.1016/j.canlet.2015.02.036 contributor: fullname: Xiao – volume: 18 start-page: 4301 year: 1998 end-page: 4314 ident: CR185 article-title: CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors publication-title: Mol. Cell Biol. doi: 10.1128/MCB.18.7.4301 contributor: fullname: Radomska – volume: 569 start-page: 73 year: 2019 end-page: 78 ident: CR50 article-title: Fatty acid transport protein 2 reprograms neutrophils in cancer publication-title: Nature doi: 10.1038/s41586-019-1118-2 contributor: fullname: Veglia – volume: 21 start-page: 2212 year: 2017 end-page: 2222 ident: CR174 article-title: CCR5 directs the mobilization of CD11b Gr1 Ly6C polymorphonuclear myeloid cells from the bone marrow to the blood to support tumor development publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.10.104 contributor: fullname: Hawila – volume: 8 year: 2013 ident: CR149 article-title: β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling publication-title: PLoS ONE doi: 10.1371/journal.pone.0079857 contributor: fullname: Feng – volume: 27 start-page: 553 year: 2014 end-page: 561 ident: CR172 article-title: Blockade of the CXCR6 signaling inhibits growth and invasion of hepatocellular carcinoma cells through inhibition of the VEGF expression publication-title: Int. J. Immunopathol. Pharmacol. doi: 10.1177/039463201402700411 contributor: fullname: Xu – volume: 34 start-page: 129 year: 2015 ident: CR84 article-title: CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-015-0247-1 contributor: fullname: Li – volume: 8 start-page: 3098 year: 2015 end-page: 3106 ident: CR77 article-title: Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis publication-title: Int. J. Clin. Exp. Med. contributor: fullname: Ma – volume: 129 start-page: 2183 year: 2011 end-page: 2193 ident: CR98 article-title: Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease publication-title: Int. J. Cancer doi: 10.1002/ijc.25892 contributor: fullname: Trellakis – volume: 15 start-page: 536 year: 2018 end-page: 554 ident: CR225 article-title: Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-018-0033-6 contributor: fullname: Greten – volume: 122 start-page: 3127 year: 2012 end-page: 3144 ident: CR169 article-title: Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis publication-title: J. Clin. Invest. doi: 10.1172/JCI61067 contributor: fullname: Jamieson – volume: 71 start-page: 2411 year: 2011 end-page: 2416 ident: CR151 article-title: Tumor-associated neutrophils: new targets for cancer therapy publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-10-2583 contributor: fullname: Houghton – volume: 18 start-page: 1414 year: 2017 ident: CR199 article-title: Histone deacetylase inhibitors as anticancer drugs publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms18071414 contributor: fullname: Hrabeta – volume: 95 year: 2016 ident: CR61 article-title: Preoperative ratio of neutrophils to lymphocytes predicts postresection survival in selected patients with early or intermediate stage hepatocellular carcinoma publication-title: Medicine doi: 10.1097/MD.0000000000002722 contributor: fullname: Lu – volume: 9 start-page: 7440 year: 2020 end-page: 7452 ident: CR87 article-title: Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma publication-title: Cancer Med. doi: 10.1002/cam4.3406 contributor: fullname: Zhu – volume: 35 start-page: 502 year: 2015 end-page: 509 ident: CR72 article-title: Neutrophil-to-lymphocyte ratio predicts mortality in patients listed for liver transplantation publication-title: Liver Int. doi: 10.1111/liv.12688 contributor: fullname: Ferguson – volume: 38 start-page: 193 year: 2020 end-page: 202 ident: CR17 article-title: Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial publication-title: J. Clin. Oncol. doi: 10.1200/JCO.19.01307 contributor: fullname: Finn – ident: CR203 – volume: 10 start-page: 2243 year: 2019 ident: CR120 article-title: S100A9 regulates MDSCs-mediated immune suppression via the RAGE and TLR4 signaling pathways in colorectal carcinoma publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02243 contributor: fullname: Huang – ident: CR53 – volume: 10 start-page: 1419 year: 2019 ident: CR224 article-title: Distinct spatio-temporal dynamics of tumor-associated neutrophils in small tumor lesions publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.01419 contributor: fullname: Sody – volume: 47 start-page: 169 year: 2018 end-page: 180 ident: CR126 article-title: High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients publication-title: Immunol. Invest. doi: 10.1080/08820139.2017.1407787 contributor: fullname: Elwan – volume: 74 start-page: 2652 year: 2021 end-page: 2669 ident: CR162 article-title: Immunomodulatory effects of lenvatinib plus anti-PD1 in mice and rationale for patient enrichment in hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.32023 contributor: fullname: Torrens – volume: 7 start-page: 8866 year: 2016 end-page: 8878 ident: CR124 article-title: Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2 publication-title: Oncotarget doi: 10.18632/oncotarget.6839 contributor: fullname: Xu – volume: 170 start-page: 1027 year: 2003 end-page: 1033 ident: CR213 article-title: Acceleration of human neutrophil apoptosis by TRAIL publication-title: J. Immunol. doi: 10.4049/jimmunol.170.2.1027 contributor: fullname: Renshaw – volume: 225 start-page: 438 year: 2011 end-page: 447 ident: CR93 article-title: Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop publication-title: J. Pathol. doi: 10.1002/path.2947 contributor: fullname: Wu – volume: 6 start-page: 1873 year: 2016 end-page: 1889 ident: CR146 article-title: Interleukin-6 enhances cancer stemness and promotes metastasis of hepatocellular carcinoma via up-regulating osteopontin expression publication-title: Am. J. Cancer Res. contributor: fullname: Wang – volume: 23 start-page: 3946 year: 2018 end-page: 3959.e3946 ident: CR159 article-title: Neutrophils kill antibody-opsonized cancer cells by trogoptosis publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.05.082 contributor: fullname: Matlung – volume: 130 start-page: 1433 year: 2000 end-page: 1452 ident: CR195 article-title: Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0703452 contributor: fullname: Giembycz – volume: 57 start-page: 1115 year: 2016 end-page: 1123 ident: CR57 article-title: Blood neutrophil-to-lymphocyte ratio predicts tumor recurrence in patients with hepatocellular carcinoma within milan criteria after hepatectomy publication-title: Yonsei Med. J. doi: 10.3349/ymj.2016.57.5.1115 contributor: fullname: Hu – volume: 70 start-page: 1564 year: 2019 end-page: 1581 ident: CR110 article-title: Receptor-interacting protein kinase 3 deficiency recruits myeloid-derived suppressor cells to hepatocellular carcinoma through the chemokine (C–X–C motif) ligand 1-chemokine (C–X–C motif) receptor 2 axis publication-title: Hepatology doi: 10.1002/hep.30676 contributor: fullname: Li – volume: 75 start-page: 1271 year: 2021 end-page: 1283 ident: CR131 article-title: Regulatory T cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis publication-title: J. Hepatol. doi: 10.1016/j.jhep.2021.07.032 contributor: fullname: Wang – volume: 21 year: 2019 ident: CR243 article-title: Neutrophil extracellular traps in breast cancer and beyond: current perspectives on NET stimuli, thrombosis and metastasis, and clinical utility for diagnosis and treatment publication-title: Breast Cancer Res. doi: 10.1186/s13058-019-1237-6 contributor: fullname: Bennewitz – volume: 37 start-page: 3216 year: 2018 end-page: 3228 ident: CR188 article-title: Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer publication-title: Oncogene doi: 10.1038/s41388-018-0126-2 contributor: fullname: Reebye – volume: 103 start-page: 891 year: 2016 end-page: 898 ident: CR64 article-title: Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma publication-title: Br. J. Surg. doi: 10.1002/bjs.10123 contributor: fullname: Okamura – volume: 99 year: 2020 ident: CR73 article-title: Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma publication-title: Medicine doi: 10.1097/MD.0000000000020919 contributor: fullname: Jia – volume: 117 start-page: 28960 year: 2020 end-page: 28970 ident: CR177 article-title: CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.2013644117 contributor: fullname: Biasci – volume: 2017 start-page: 7989020 year: 2017 ident: CR35 article-title: Comparison of myeloid cells in circulation and in the tumor microenvironment of patients with colorectal and breast cancers publication-title: J. Immunol. Res. doi: 10.1155/2017/7989020 contributor: fullname: Elkord – volume: 389 start-page: 2492 year: 2017 end-page: 2502 ident: CR16 article-title: Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial publication-title: Lancet doi: 10.1016/S0140-6736(17)31046-2 contributor: fullname: El-Khoueiry – volume: 19 start-page: 1803 year: 2018 ident: CR201 article-title: STAT3 in tumor-associated myeloid cells: multitasking to disrupt immunity publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms19061803 contributor: fullname: Kortylewski – volume: 17 start-page: 457 year: 2020 end-page: 472 ident: CR41 article-title: Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-020-0304-x contributor: fullname: Henderson – volume: 5 year: 2016 ident: CR92 article-title: Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1219828 contributor: fullname: He – volume: 25 start-page: 435 year: 2013 end-page: 441 ident: CR71 article-title: Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis publication-title: Eur. J. Gastroenterol. Hepatol. doi: 10.1097/MEG.0b013e32835c2af3 contributor: fullname: Biyik – volume: 380 start-page: 1450 year: 2019 end-page: 1462 ident: CR2 article-title: Hepatocellular carcinoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1713263 contributor: fullname: Villanueva – volume: 7 year: 2017 ident: CR187 article-title: Dual negative roles of C/EBPα in the expansion and pro-tumor functions of MDSCs publication-title: Sci. Rep. doi: 10.1038/s41598-017-12968-2 contributor: fullname: Mackert – volume: 2 start-page: 461 year: 2007 end-page: 465 ident: CR210 article-title: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling publication-title: J. Thorac. Oncol. doi: 10.1097/JTO.0b013e31805fea64 contributor: fullname: Thorburn – volume: 1 start-page: 674 year: 2002 end-page: 682 ident: CR193 article-title: Phosphodiesterase 5 inhibitors: current status and potential applications publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd893 contributor: fullname: Rotella – volume: 120 start-page: 1240 year: 1978 end-page: 1248 ident: CR153 article-title: Immunologic rejection of mammary adenocarcinoma (TA3-St) in C57BL/6 mice: participation of neutrophils and activated macrophages with fibrin formation publication-title: J. Immunol. contributor: fullname: Dvorak – volume: 14 start-page: 399 year: 2017 end-page: 416 ident: CR22 article-title: Tumour-associated macrophages as treatment targets in oncology publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/nrclinonc.2016.217 contributor: fullname: Allavena – volume: 40 start-page: 785 year: 2014 end-page: 800 ident: CR36 article-title: γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer publication-title: Immunity doi: 10.1016/j.immuni.2014.03.013 contributor: fullname: Wu – volume: 61 start-page: 1591 year: 2015 end-page: 1602 ident: CR175 article-title: CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice publication-title: Hepatology doi: 10.1002/hep.27665 contributor: fullname: Chen – volume: 11 start-page: 890 year: 2011 end-page: 898 ident: CR182 article-title: Icaritin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2011.01.007 contributor: fullname: Zhou – volume: 38 start-page: 4534 year: 1978 end-page: 4539 ident: CR152 article-title: Selective reduction of human tumor cell populations by human granulocytes in vitro publication-title: Cancer Res. contributor: fullname: Morton – volume: 18 start-page: 38 year: 2021 end-page: 44 ident: CR9 article-title: Neutrophils in liver diseases: pathogenesis and therapeutic targets publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-020-00560-0 contributor: fullname: Xu – volume: 64 start-page: 797 year: 2016 end-page: 813 ident: CR105 article-title: Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C–C motif) ligand 26 publication-title: Hepatology doi: 10.1002/hep.28655 contributor: fullname: Chiu – volume: 183 start-page: 771 year: 2020 end-page: 785.e712 ident: CR154 article-title: Innate immune training of granulopoiesis promotes anti-tumor activity publication-title: Cell doi: 10.1016/j.cell.2020.09.058 contributor: fullname: Kalafati – volume: 9 start-page: 1310 year: 2018 ident: CR167 article-title: Myeloid-derived suppressor cells hinder the anti-cancer activity of immune checkpoint inhibitors publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.01310 contributor: fullname: Weber – volume: 54 start-page: 497 year: 2011 end-page: 505 ident: CR86 article-title: Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection publication-title: J. Hepatol. doi: 10.1016/j.jhep.2010.07.044 contributor: fullname: Li – volume: 63 start-page: 420 year: 2015 end-page: 428 ident: CR132 article-title: Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.03.024 contributor: fullname: Gong – volume: 20 start-page: 485 year: 2020 end-page: 503 ident: CR238 article-title: Neutrophil diversity and plasticity in tumour progression and therapy publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-020-0281-y contributor: fullname: Jaillon – ident: CR42 – volume: 24 year: 2019 ident: CR166 article-title: Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC publication-title: JCI Insight doi: 10.1172/jci.insight.130850 contributor: fullname: Kargl – volume: 13 start-page: 16367 year: 2021 end-page: 16380 ident: CR118 article-title: High S100A9 cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection publication-title: Aging doi: 10.18632/aging.203162 contributor: fullname: Liao – ident: CR101 – volume: 71 start-page: 209 year: 2021 end-page: 249 ident: CR1 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 contributor: fullname: Sung – volume: 11 start-page: 1248 year: 2021 end-page: 1267 ident: CR237 article-title: Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-20-0304 contributor: fullname: Zhang – volume: 150 start-page: 1646 year: 2016 end-page: 1658.e1617 ident: CR37 article-title: Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.02.040 contributor: fullname: Zhou – volume: 10 year: 2012 ident: CR116 article-title: Hepatocyte-specific S100a8 and S100a9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichment publication-title: Cell Commun. Signal. doi: 10.1186/1478-811X-10-40 contributor: fullname: Wiechert – ident: CR204 – volume: 70 start-page: 1214 year: 2019 end-page: 1230 ident: CR113 article-title: A positive feedback loop between cancer stem-like cells and tumor-associated neutrophils controls hepatocellular carcinoma progression publication-title: Hepatology doi: 10.1002/hep.30630 contributor: fullname: Zhou – volume: 56 start-page: 2242 year: 2012 end-page: 2254 ident: CR91 article-title: Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.25907 contributor: fullname: Zhou – volume: 39 start-page: 267 year: 2021 ident: CR18 article-title: IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC) publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2021.39.3_suppl.267 contributor: fullname: Finn – volume: 486 start-page: 239 year: 2017 end-page: 244 ident: CR179 article-title: IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2017.02.128 contributor: fullname: Lu – volume: 30 start-page: 5663 year: 2020 end-page: 5673 ident: CR65 article-title: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE publication-title: Eur. Radiol. doi: 10.1007/s00330-020-06931-5 contributor: fullname: Schobert – volume: 6 start-page: 31927 year: 2015 end-page: 31943 ident: CR181 article-title: A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/JAK2/STAT3 pathway publication-title: Oncotarget doi: 10.18632/oncotarget.5578 contributor: fullname: Zhao – volume: 115 start-page: 211 year: 2015 end-page: 216 ident: CR163 article-title: Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma publication-title: Radiother. Oncol. doi: 10.1016/j.radonc.2015.04.006 contributor: fullname: Huertas – volume: 172 start-page: 989 year: 2004 end-page: 999 ident: CR40 article-title: Antigen-specific inhibition of CD8 T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species publication-title: J. Immunol. doi: 10.4049/jimmunol.172.2.989 contributor: fullname: Gabrilovich – volume: 5 year: 2016 ident: CR222 article-title: Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotype publication-title: OncoImmunology doi: 10.1080/2162402X.2015.1067744 contributor: fullname: Shrestha – volume: 10 start-page: 1912 year: 2019 ident: CR51 article-title: Neutrophil maturity in cancer publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.01912 contributor: fullname: Carlin – volume: 23 start-page: 190 year: 2013 end-page: 199 ident: CR158 article-title: Neutrophils as effector cells for antibody-based immunotherapy of cancer publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2012.12.002 contributor: fullname: Bakema – volume: 108 start-page: 1627 year: 2006 end-page: 1634 ident: CR32 article-title: Suppression of T-cell functions by human granulocyte arginase publication-title: Blood doi: 10.1182/blood-2006-11-010389 contributor: fullname: Munder – volume: 9 start-page: 3017 year: 2016 end-page: 3023 ident: CR80 article-title: Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports publication-title: Onco Targets Ther. contributor: fullname: Sun – volume: 10 start-page: 3130 year: 2019 ident: CR229 article-title: Mouse models and tools for the in vivo study of neutrophils publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.03130 contributor: fullname: Reber – volume: 6 start-page: 846 year: 2015 end-page: 861 ident: CR111 article-title: PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma publication-title: Oncotarget doi: 10.18632/oncotarget.2749 contributor: fullname: Liu – volume: 7 start-page: 6 year: 2021 ident: CR3 article-title: Hepatocellular carcinoma publication-title: Nat. Rev. Dis. Primers doi: 10.1038/s41572-020-00240-3 contributor: fullname: Llovet – volume: 20 start-page: 5079 year: 2019 ident: CR122 article-title: Hepatic stellate cells enhance liver cancer progression by inducing myeloid-derived suppressor cells through interleukin-6 signaling publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20205079 contributor: fullname: He – volume: 19 start-page: 222 year: 2018 end-page: 232 ident: CR5 article-title: The immunology of hepatocellular carcinoma publication-title: Nat. Immunol. doi: 10.1038/s41590-018-0044-z contributor: fullname: Heikenwalder – ident: CR171 – volume: 16 start-page: 601 year: 2019 end-page: 620 ident: CR14 article-title: Tumour-associated neutrophils in patients with cancer publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/s41571-019-0222-4 contributor: fullname: Fridlender – volume: 66 start-page: 743 year: 2017 end-page: 753 ident: CR106 article-title: Functional role of CCL5/RANTES for HCC progression during chronic liver disease publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.12.011 contributor: fullname: Mohs – volume: 120 start-page: 69 year: 2019 end-page: 78 ident: CR161 article-title: Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer publication-title: Br. J. Cancer doi: 10.1038/s41416-018-0198-3 contributor: fullname: Schiffmann – volume: 16 start-page: 440 year: 2016 ident: CR219 article-title: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth publication-title: BMC Cancer doi: 10.1186/s12885-016-2481-0 contributor: fullname: Ivars – volume: 144 start-page: 136 year: 2019 end-page: 149 ident: CR221 article-title: NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophils publication-title: Int. J. Cancer doi: 10.1002/ijc.31808 contributor: fullname: Pylaeva – volume: 58 start-page: 705 year: 1976 end-page: 715 ident: CR11 article-title: Neutrophil kinetics in man publication-title: J. Clin. Invest. doi: 10.1172/JCI108517 contributor: fullname: Finch – volume: 12 start-page: 3341 year: 2021 ident: CR43 article-title: Quantitative single-cell proteomics as a tool to characterize cellular hierarchies publication-title: Nat. Commun. doi: 10.1038/s41467-021-23667-y contributor: fullname: Schoof – volume: 44 start-page: 639 year: 2014 end-page: 650 ident: CR127 article-title: Increased circulating Lin CD33 HLA-DR myeloid-derived suppressor cells in hepatocellular carcinoma patients publication-title: Hepatol. Res. doi: 10.1111/hepr.12167 contributor: fullname: Zheng – volume: 26 start-page: 3936 year: 2020 end-page: 3946 ident: CR189 article-title: MTL-CEBPA, a small activating RNA therapeutic upregulating C/EBP-α, in patients with advanced liver cancer: a first-in-human, multicenter, open-label, phase I trial publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-20-0414 contributor: fullname: Sarker – volume: 23 start-page: 1255 year: 2015 end-page: 1269 ident: CR231 article-title: Myeloperoxidase-hepatocyte-stellate cell cross talk promotes hepatocyte injury and fibrosis in experimental nonalcoholic steatohepatitis publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2014.6108 contributor: fullname: Pulli – volume: 43 start-page: 757 year: 2013 end-page: 764 ident: CR60 article-title: Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma publication-title: Hepatol. Res. doi: 10.1111/hepr.12019 contributor: fullname: Limaye – volume: 93 start-page: 273 year: 2005 end-page: 278 ident: CR78 article-title: Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6602702 contributor: fullname: Schmidt – volume: 114 start-page: 612 year: 2016 end-page: 615 ident: CR74 article-title: Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study publication-title: Br. J. Cancer doi: 10.1038/bjc.2016.23 contributor: fullname: Grenader – volume: 10 start-page: 1696 year: 2020 ident: CR227 article-title: Humanized rodent models for cancer research publication-title: Front. Oncol. doi: 10.3389/fonc.2020.01696 contributor: fullname: Hu – volume: 112 start-page: E566 year: 2015 end-page: E575 ident: CR52 article-title: Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1424927112 contributor: fullname: Casbon – volume: 9 start-page: 162 year: 2009 end-page: 174 ident: CR46 article-title: Myeloid-derived suppressor cells as regulators of the immune system publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2506 contributor: fullname: Nagaraj – volume: 237 start-page: 85 year: 2015 end-page: 97 ident: CR168 article-title: CXCR2 inhibition suppresses acute and chronic pancreatic inflammation publication-title: J. Pathol. doi: 10.1002/path.4555 contributor: fullname: Steele – volume: 93 start-page: 1034 year: 2003 end-page: 1046 ident: CR192 article-title: Regulation of gene expression by cyclic GMP publication-title: Circ. Res. doi: 10.1161/01.RES.0000103311.52853.48 contributor: fullname: Casteel – volume: 73 start-page: 906 year: 2020 end-page: 917 ident: CR112 article-title: Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.05.004 contributor: fullname: Peng – ident: CR4 – ident: CR240 – volume: 13 start-page: 3 year: 2020 ident: CR150 article-title: Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-019-0836-0 contributor: fullname: Yang – volume: 382 start-page: 1894 year: 2020 end-page: 1905 ident: CR15 article-title: Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1915745 contributor: fullname: Finn – volume: 113 start-page: 11300 year: 2016 end-page: 11305 ident: CR38 article-title: Key role for neutrophils in radiation-induced antitumor immune responses: potentiation with G-CSF publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1613187113 contributor: fullname: Takeshima – volume: 10 start-page: 562 year: 2015 end-page: 573 ident: CR33 article-title: Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.12.039 contributor: fullname: Sagiv – volume: 12 start-page: 912 year: 2020 end-page: 930 ident: CR88 article-title: Prognostic potential of PRPF3 in hepatocellular carcinoma publication-title: Aging doi: 10.18632/aging.102665 contributor: fullname: Liu – volume: 62 start-page: 534 year: 2015 end-page: 545 ident: CR207 article-title: Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice publication-title: Hepatology doi: 10.1002/hep.27859 contributor: fullname: Lo – volume: 50 start-page: 924 year: 2019 end-page: 940 ident: CR144 article-title: Transforming growth factor-β signaling in immunity and cancer publication-title: Immunity doi: 10.1016/j.immuni.2019.03.024 contributor: fullname: Massagué – volume: 10 start-page: 4 year: 2020 ident: CR164 article-title: Hypofractionated irradiation suppressed the off-target mouse hepatocarcinoma growth by inhibiting myeloid-derived suppressor cell-mediated immune suppression publication-title: Front. Oncol. doi: 10.3389/fonc.2020.00004 contributor: fullname: Chen – volume: 19 year: 2019 ident: CR180 article-title: First-in-class immune-modulating small molecule icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers publication-title: BMC Cancer doi: 10.1186/s12885-019-5471-1 contributor: fullname: Fan – volume: 52 start-page: 856 year: 2020 end-page: 871.e858 ident: CR148 article-title: CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity publication-title: Immunity doi: 10.1016/j.immuni.2020.03.001 contributor: fullname: Teijeira – volume: 60 start-page: 179 year: 2014 end-page: 191 ident: CR206 article-title: Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.27070 contributor: fullname: Lee – volume: 36 start-page: 342 year: 2002 end-page: 348 ident: CR233 article-title: Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis publication-title: J. Hepatol. doi: 10.1016/S0168-8278(01)00276-8 contributor: fullname: Taïeb – volume: 9 start-page: 664 year: 2019 ident: CR85 article-title: Identification and validation of tumor stromal immunotype in patients with hepatocellular carcinoma publication-title: Front. Oncol. doi: 10.3389/fonc.2019.00664 contributor: fullname: Wu – volume: 19 year: 2019 ident: CR191 article-title: Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data publication-title: BMC Cancer doi: 10.1186/s12885-019-5740-z contributor: fullname: Yoon – volume: 351 start-page: 142 year: 2017 end-page: 149 ident: CR123 article-title: Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2017.01.008 contributor: fullname: Xu – volume: 3 start-page: 263 year: 2012 ident: CR165 article-title: CXCR2: from bench to bedside publication-title: Front. Immunol. doi: 10.3389/fimmu.2012.00263 contributor: fullname: Zarbock – volume: 9 start-page: 113 year: 2018 ident: CR8 article-title: Neutrophil: a cell with many roles in inflammation or several cell types? publication-title: Front. Physiol. doi: 10.3389/fphys.2018.00113 contributor: fullname: Rosales – volume: 7 start-page: 50963 year: 2016 end-page: 50971 ident: CR76 article-title: Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma publication-title: Oncotarget doi: 10.18632/oncotarget.7680 contributor: fullname: Lin – volume: 25 start-page: 2705 year: 2017 end-page: 2714 ident: CR186 article-title: Development and mechanism of small activating RNA targeting CEBPA, a novel therapeutic in clinical trials for liver cancer publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.07.018 contributor: fullname: Voutila – volume: 78 start-page: 2680 year: 2018 end-page: 2690 ident: CR155 article-title: TRPM2 mediates neutrophil killing of disseminated tumor cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-17-3614 contributor: fullname: Gershkovitz – ident: CR239 – volume: 9 start-page: 1298 year: 2018 ident: CR114 article-title: S100A8/A9 in inflammation publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.01298 contributor: fullname: Wang – volume: 27 start-page: 4709 year: 2009 end-page: 4717 ident: CR96 article-title: Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2008.18.9498 contributor: fullname: Jensen – volume: 368 start-page: 973 year: 2020 end-page: 980 ident: CR236 article-title: The human tumor microbiome is composed of tumor type–specific intracellular bacteria publication-title: Science doi: 10.1126/science.aay9189 contributor: fullname: Nejman – volume: 124 start-page: 2626 year: 2014 end-page: 2639 ident: CR211 article-title: ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis publication-title: J. Clin. Invest. doi: 10.1172/JCI74056 contributor: fullname: Condamine – volume: 24 start-page: 908 year: 2018 end-page: 922 ident: CR230 article-title: Mechanisms of NAFLD development and therapeutic strategies publication-title: Nat. Med. doi: 10.1038/s41591-018-0104-9 contributor: fullname: Sanyal – volume: 118 start-page: 248 year: 2018 end-page: 257 ident: CR62 article-title: Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma? publication-title: Br. J. Cancer doi: 10.1038/bjc.2017.386 contributor: fullname: Margetts – volume: 37 start-page: 118 year: 2019 end-page: 126 ident: CR183 article-title: A phase 1b study of transforming growth factor-beta receptor I inhibitor galunisertib in combination with sorafenib in Japanese patients with unresectable hepatocellular carcinoma publication-title: Invest. N. Drugs doi: 10.1007/s10637-018-0636-3 contributor: fullname: Ikeda – volume: 135 start-page: 1178 year: 2014 end-page: 1186 ident: CR31 article-title: Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17 — a new mechanism of impaired antitumor immunity publication-title: Int. J. Cancer doi: 10.1002/ijc.28770 contributor: fullname: Mishalian – volume: 3 start-page: 80 year: 2020 end-page: 94 ident: CR209 article-title: Macrophage checkpoint blockade: results from initial clinical trials, binding analyses, and CD47-SIRPα structure-function publication-title: Antib. Ther. contributor: fullname: Discher – volume: 40 year: 2021 ident: CR129 article-title: Neutrophils induce paracrine telomere dysfunction and senescence in ROS-dependent manner publication-title: EMBO J. doi: 10.15252/embj.2020106048 contributor: fullname: Lagnado – volume: 3 start-page: 136 year: 2015 end-page: 148 ident: CR217 article-title: Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-14-0036 contributor: fullname: Shen – volume: 11 year: 2020 ident: CR234 article-title: Dual roles of neutrophils in metastatic colonization are governed by the host NK cell status publication-title: Nat. Commun. doi: 10.1038/s41467-020-18125-0 contributor: fullname: Li – volume: 98 start-page: 349 year: 1999 end-page: 354 ident: CR94 article-title: Neutrophil infiltration into human gliomas publication-title: Acta Neuropathol. doi: 10.1007/s004010051093 contributor: fullname: Fossati – volume: 176 start-page: 1271 year: 2010 end-page: 1281 ident: CR232 article-title: Neutrophil depletion blocks early collagen degradation in repairing cholestatic rat livers publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2010.090527 contributor: fullname: Harty – volume: 7 year: 2012 ident: CR99 article-title: The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection publication-title: PLoS ONE doi: 10.1371/journal.pone.0033655 contributor: fullname: Zhao – volume: 120 start-page: 2423 year: 2010 end-page: 2431 ident: CR102 article-title: CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow publication-title: J. Clin. Invest. doi: 10.1172/JCI41649 contributor: fullname: Link – volume: 30 start-page: 120 year: 2016 end-page: 135 ident: CR157 article-title: Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.06.001 contributor: fullname: Singhal – volume: 22 year: 2020 ident: CR82 article-title: Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: a gene expression-based study publication-title: J. Gene Med. doi: 10.1002/jgm.3155 contributor: fullname: Ren – volume: 6 year: 2015 ident: CR115 article-title: NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma publication-title: Nat. Commun. doi: 10.1038/ncomms7818 contributor: fullname: Wilson – volume: 26 year: 2020 ident: CR58 article-title: The prognostic role of a combined fibrinogen and neutrophil-to-lymphocyte ratio score in patients with resectable hepatocellular carcinoma: a retrospective study publication-title: Med. Sci. Monit. doi: 10.12659/MSM.918824 contributor: fullname: Kong – volume: 83 start-page: 64 year: 2008 end-page: 70 ident: CR20 article-title: Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0407247 contributor: fullname: Albina – volume: 9 year: 2018 ident: CR104 article-title: Cancer-associated fibroblasts induce PDL1 neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma publication-title: Cell Death Dis. doi: 10.1038/s41419-018-0458-4 contributor: fullname: Cheng – volume: 65 start-page: 3044 year: 2005 end-page: 3048 ident: CR49 article-title: Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-4505 contributor: fullname: Zea – volume: 12 start-page: 7173 year: 2020 end-page: 7188 ident: CR56 article-title: The prognostic value of inflammation factors in hepatocellular carcinoma patients with hepatic artery interventional treatments: a retrospective study publication-title: Cancer Manag. Res. doi: 10.2147/CMAR.S257934 contributor: fullname: Guo – volume: 182 start-page: 240 year: 2009 end-page: 249 ident: CR137 article-title: Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-β1 publication-title: J. Immunol. doi: 10.4049/jimmunol.182.1.240 contributor: fullname: Cao – volume: 67 start-page: 931 year: 2018 end-page: 944 ident: CR125 article-title: Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy publication-title: Gut doi: 10.1136/gutjnl-2017-314032 contributor: fullname: Zhou – volume: 123 start-page: 1911 year: 2013 end-page: 1918 ident: CR145 article-title: Cancer stem cells in the development of liver cancer publication-title: J. Clin. Invest. doi: 10.1172/JCI66024 contributor: fullname: Wang – volume: 17 start-page: 433 year: 2020 end-page: 450 ident: CR103 article-title: Neutrophil chemoattractant receptors in health and disease: double-edged swords publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-020-0412-0 contributor: fullname: Proost – volume: 5 year: 2015 ident: CR81 article-title: Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis publication-title: BMJ Open doi: 10.1136/bmjopen-2014-006404 contributor: fullname: Zhang – volume: 1835 start-page: 100 year: 2013 end-page: 109 ident: CR215 article-title: Review of S100A9 biology and its role in cancer publication-title: Biochim. Biophys. Acta contributor: fullname: Carson – volume: 45 start-page: 949 year: 2015 end-page: 959 ident: CR69 article-title: Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy publication-title: Hepatol. Res. doi: 10.1111/hepr.12436 contributor: fullname: Terashima – volume: 40 start-page: 365 year: 2018 end-page: 371 ident: CR67 article-title: Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection. [in Chinese] publication-title: Zhonghua Zhong Liu Za Zhi contributor: fullname: Wu – volume: 60 start-page: 110 year: 2014 end-page: 117 ident: CR100 article-title: Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team publication-title: J. Hepatol. doi: 10.1016/j.jhep.2013.08.011 contributor: fullname: Dyson – volume: 7 start-page: 1131 year: 1993 end-page: 1141 ident: CR194 article-title: Interleukin-4 and its receptor; modulating effects on immature and mature hematopoietic cells publication-title: Leukemia contributor: fullname: Halie – volume: 8 start-page: 24380 year: 2017 end-page: 24388 ident: CR59 article-title: Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value of for hepatocellular carcinoma patients publication-title: Oncotarget doi: 10.18632/oncotarget.15456 contributor: fullname: Li – volume: 183 start-page: 1282 year: 2020 end-page: 1297.e1 ident: CR13 article-title: Co-option of neutrophil fates by tissue environments publication-title: Cell doi: 10.1016/j.cell.2020.10.003 contributor: fullname: Ballesteros – volume: 124 start-page: 5466 year: 2014 end-page: 5480 ident: CR26 article-title: Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer publication-title: J. Clin. Invest. doi: 10.1172/JCI77053 contributor: fullname: Eruslanov – volume: 6 year: 2016 ident: CR75 article-title: Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients publication-title: Sci. Rep. doi: 10.1038/srep22089 contributor: fullname: Gu – volume: 69 start-page: 840 year: 2018 end-page: 850 ident: CR226 article-title: Mutational landscape of a chemically-induced mouse model of liver cancer publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.06.009 contributor: fullname: Connor – volume: 68 start-page: 1347 year: 2018 end-page: 1360 ident: CR130 article-title: Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.29914 contributor: fullname: van der Windt – volume: 229 start-page: 114 year: 2009 ident: 568_CR140 publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2009.00767.x contributor: fullname: JL Riley – volume: 1 start-page: 674 year: 2002 ident: 568_CR193 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd893 contributor: fullname: DP Rotella – volume: 380 start-page: 1450 year: 2019 ident: 568_CR2 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1713263 contributor: fullname: A Villanueva – volume: 13 start-page: 3 year: 2020 ident: 568_CR150 publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-019-0836-0 contributor: fullname: LY Yang – ident: 568_CR242 – volume: 18 start-page: 176 year: 2020 ident: 568_CR89 publication-title: World J. Surg. Oncol. doi: 10.1186/s12957-020-01953-1 contributor: fullname: D Song – volume: 135 start-page: 1178 year: 2014 ident: 568_CR31 publication-title: Int. J. Cancer doi: 10.1002/ijc.28770 contributor: fullname: I Mishalian – volume: 13 start-page: 16367 year: 2021 ident: 568_CR118 publication-title: Aging doi: 10.18632/aging.203162 contributor: fullname: J Liao – volume: 35 start-page: 19 year: 2018 ident: 568_CR178 publication-title: Semin. Immunol. doi: 10.1016/j.smim.2017.12.004 contributor: fullname: J Zhou – volume: 99 year: 2020 ident: 568_CR73 publication-title: Medicine doi: 10.1097/MD.0000000000020919 contributor: fullname: SC Li – volume: 30 start-page: 3361 year: 2012 ident: 568_CR198 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2011.41.2395 contributor: fullname: W Yeo – volume: 58 start-page: 705 year: 1976 ident: 568_CR11 publication-title: J. Clin. Invest. doi: 10.1172/JCI108517 contributor: fullname: JT Dancey – volume: 74 start-page: 2652 year: 2021 ident: 568_CR162 publication-title: Hepatology doi: 10.1002/hep.32023 contributor: fullname: L Torrens – volume: 70 start-page: 449 year: 2019 ident: 568_CR139 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.10.040 contributor: fullname: SJ Yu – volume: 40 start-page: 785 year: 2014 ident: 568_CR36 publication-title: Immunity doi: 10.1016/j.immuni.2014.03.013 contributor: fullname: P Wu – volume: 7 start-page: 6 year: 2021 ident: 568_CR3 publication-title: Nat. Rev. Dis. Primers doi: 10.1038/s41572-020-00240-3 contributor: fullname: JM Llovet – volume: 61 start-page: 1591 year: 2015 ident: 568_CR175 publication-title: Hepatology doi: 10.1002/hep.27665 contributor: fullname: Y Chen – volume: 7 year: 2009 ident: 568_CR216 publication-title: PLoS Biol. doi: 10.1371/journal.pbio.1000097 contributor: fullname: P Björk – volume: 68 start-page: 1959 year: 2019 ident: 568_CR107 publication-title: Cancer Immunol. Immunother. doi: 10.1007/s00262-019-02414-9 contributor: fullname: Y Xu – volume: 26 start-page: 3936 year: 2020 ident: 568_CR189 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-20-0414 contributor: fullname: D Sarker – volume: 103 start-page: 891 year: 2016 ident: 568_CR64 publication-title: Br. J. Surg. doi: 10.1002/bjs.10123 contributor: fullname: Y Okamura – volume: 7 start-page: 8866 year: 2016 ident: 568_CR124 publication-title: Oncotarget doi: 10.18632/oncotarget.6839 contributor: fullname: Y Xu – volume: 113 start-page: 11300 year: 2016 ident: 568_CR38 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1613187113 contributor: fullname: T Takeshima – volume: 10 start-page: 2243 year: 2019 ident: 568_CR120 publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02243 contributor: fullname: M Huang – volume: 12 year: 2021 ident: 568_CR55 publication-title: Nat. Commun. doi: 10.1038/s41467-021-22973-9 contributor: fullname: R Grieshaber-Bouyer – volume: 14 start-page: 163 year: 2000 ident: 568_CR147 publication-title: Genes Dev. doi: 10.1101/gad.14.2.163 contributor: fullname: Q Yu – volume: 37 start-page: 118 year: 2019 ident: 568_CR183 publication-title: Invest. N. Drugs doi: 10.1007/s10637-018-0636-3 contributor: fullname: M Ikeda – volume: 60 start-page: 110 year: 2014 ident: 568_CR100 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2013.08.011 contributor: fullname: J Dyson – volume: 20 start-page: 5079 year: 2019 ident: 568_CR122 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20205079 contributor: fullname: CC Hsieh – volume: 9 start-page: 4962 year: 2020 ident: 568_CR70 publication-title: Cancer Med. doi: 10.1002/cam4.3135 contributor: fullname: S Dharmapuri – volume: 19 year: 2019 ident: 568_CR180 publication-title: BMC Cancer doi: 10.1186/s12885-019-5471-1 contributor: fullname: Y Fan – ident: 568_CR53 doi: 10.1038/s41577-021-00571-6 – volume: 351 start-page: 142 year: 2017 ident: 568_CR123 publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2017.01.008 contributor: fullname: M Xu – volume: 118 year: 2021 ident: 568_CR176 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.2015433118 contributor: fullname: J-S Song – volume: 11 start-page: 1248 year: 2021 ident: 568_CR237 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-20-0304 contributor: fullname: Q Zhang – volume: 33 start-page: 657 year: 2010 ident: 568_CR6 publication-title: Immunity doi: 10.1016/j.immuni.2010.11.011 contributor: fullname: N Borregaard – volume: 24 start-page: 908 year: 2018 ident: 568_CR230 publication-title: Nat. Med. doi: 10.1038/s41591-018-0104-9 contributor: fullname: SL Friedman – volume: 19 start-page: 1803 year: 2018 ident: 568_CR201 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms19061803 contributor: fullname: YL Su – ident: 568_CR202 – volume: 11 start-page: 890 year: 2011 ident: 568_CR182 publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2011.01.007 contributor: fullname: J Zhou – volume: 389 start-page: 2492 year: 2017 ident: 568_CR16 publication-title: Lancet doi: 10.1016/S0140-6736(17)31046-2 contributor: fullname: AB El-Khoueiry – volume: 6 start-page: 348 year: 2018 ident: 568_CR235 publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-17-0204 contributor: fullname: K Ogura – volume: 8 year: 2013 ident: 568_CR149 publication-title: PLoS ONE doi: 10.1371/journal.pone.0079857 contributor: fullname: XX Feng – volume: 17 start-page: 147 year: 2019 ident: 568_CR7 publication-title: Cell Commun. Signal. doi: 10.1186/s12964-019-0471-y contributor: fullname: Y Li – volume: 63 start-page: 896 year: 2015 ident: 568_CR214 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.06.001 contributor: fullname: AL Cheng – volume: 9 start-page: 7440 year: 2020 ident: 568_CR87 publication-title: Cancer Med. doi: 10.1002/cam4.3406 contributor: fullname: T Liu – volume: 44 start-page: 639 year: 2014 ident: 568_CR127 publication-title: Hepatol. Res. doi: 10.1111/hepr.12167 contributor: fullname: P Shen – volume: 14 start-page: 399 year: 2017 ident: 568_CR22 publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/nrclinonc.2016.217 contributor: fullname: A Mantovani – volume: 10 start-page: 4 year: 2020 ident: 568_CR164 publication-title: Front. Oncol. doi: 10.3389/fonc.2020.00004 contributor: fullname: J Chen – volume: 5 year: 2015 ident: 568_CR81 publication-title: BMJ Open doi: 10.1136/bmjopen-2014-006404 contributor: fullname: K Hu – volume: 136 start-page: 35 year: 2010 ident: 568_CR48 publication-title: J. Cancer Res. Clin. Oncol. doi: 10.1007/s00432-009-0634-0 contributor: fullname: CY Liu – volume: 7 year: 2012 ident: 568_CR99 publication-title: PLoS ONE doi: 10.1371/journal.pone.0033655 contributor: fullname: JJ Zhao – volume: 47 start-page: 169 year: 2018 ident: 568_CR126 publication-title: Immunol. Invest. doi: 10.1080/08820139.2017.1407787 contributor: fullname: N Elwan – volume: 50 start-page: 1251 year: 2009 ident: 568_CR117 publication-title: Hepatology doi: 10.1002/hep.23099 contributor: fullname: J Németh – volume: 19 year: 2019 ident: 568_CR191 publication-title: BMC Cancer doi: 10.1186/s12885-019-5740-z contributor: fullname: JS Yoon – volume: 68 start-page: 1347 year: 2018 ident: 568_CR130 publication-title: Hepatology doi: 10.1002/hep.29914 contributor: fullname: DJ van der Windt – ident: 568_CR241 – volume: 38 start-page: 4534 year: 1978 ident: 568_CR152 publication-title: Cancer Res. contributor: fullname: DO Chee – volume: 69 start-page: 840 year: 2018 ident: 568_CR226 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.06.009 contributor: fullname: F Connor – volume: 108 start-page: 1627 year: 2006 ident: 568_CR32 publication-title: Blood doi: 10.1182/blood-2006-11-010389 contributor: fullname: M Munder – volume: 6 start-page: 31927 year: 2015 ident: 568_CR181 publication-title: Oncotarget doi: 10.18632/oncotarget.5578 contributor: fullname: H Zhao – volume: 6 start-page: 1873 year: 2016 ident: 568_CR146 publication-title: Am. J. Cancer Res. contributor: fullname: CQ Wang – volume: 142 start-page: 1878 year: 2018 ident: 568_CR133 publication-title: Int. J. Cancer doi: 10.1002/ijc.31216 contributor: fullname: CJ Chang – volume: 71 start-page: 2411 year: 2011 ident: 568_CR151 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-10-2583 contributor: fullname: AD Gregory – volume: 3 start-page: 263 year: 2012 ident: 568_CR165 publication-title: Front. Immunol. doi: 10.3389/fimmu.2012.00263 contributor: fullname: A Stadtmann – volume: 37 start-page: 3216 year: 2018 ident: 568_CR188 publication-title: Oncogene doi: 10.1038/s41388-018-0126-2 contributor: fullname: V Reebye – volume: 34 start-page: 141 year: 2015 ident: 568_CR29 publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-015-0256-0 contributor: fullname: G He – volume: 91 start-page: 591 year: 2012 ident: 568_CR25 publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0411193 contributor: fullname: CA Dumitru – volume: 10 year: 2012 ident: 568_CR116 publication-title: Cell Commun. Signal. doi: 10.1186/1478-811X-10-40 contributor: fullname: L Wiechert – volume: 11 year: 2020 ident: 568_CR234 publication-title: Nat. Commun. doi: 10.1038/s41467-020-18125-0 contributor: fullname: P Li – volume: 23 start-page: 190 year: 2013 ident: 568_CR158 publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2012.12.002 contributor: fullname: M van Egmond – volume: 93 start-page: 1034 year: 2003 ident: 568_CR192 publication-title: Circ. Res. doi: 10.1161/01.RES.0000103311.52853.48 contributor: fullname: RB Pilz – volume: 83 start-page: 64 year: 2008 ident: 568_CR20 publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0407247 contributor: fullname: JM Daley – volume: 188 start-page: 96 year: 2017 ident: 568_CR108 publication-title: Clin. Exp. Immunol. doi: 10.1111/cei.12917 contributor: fullname: H Zhang – volume: 40 start-page: 365 year: 2018 ident: 568_CR67 publication-title: Zhonghua Zhong Liu Za Zhi contributor: fullname: XL Wu – volume: 54 start-page: 948 year: 2011 ident: 568_CR30 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2010.08.041 contributor: fullname: DM Kuang – volume: 150 start-page: 1646 year: 2016 ident: 568_CR37 publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.02.040 contributor: fullname: SL Zhou – volume: 9 start-page: 1310 year: 2018 ident: 568_CR167 publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.01310 contributor: fullname: R Weber – volume: 75 start-page: 1271 year: 2021 ident: 568_CR131 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2021.07.032 contributor: fullname: H Wang – volume: 2 start-page: 461 year: 2007 ident: 568_CR210 publication-title: J. Thorac. Oncol. doi: 10.1097/JTO.0b013e31805fea64 contributor: fullname: A Thorburn – volume: 40 year: 2021 ident: 568_CR129 publication-title: EMBO J. doi: 10.15252/embj.2020106048 contributor: fullname: A Lagnado – volume: 93 start-page: 273 year: 2005 ident: 568_CR78 publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6602702 contributor: fullname: H Schmidt – volume: 11 start-page: 2762 year: 2020 ident: 568_CR223 publication-title: Nat. Commun. doi: 10.1038/s41467-020-16596-9 contributor: fullname: G Boivin – volume: 71 start-page: 209 year: 2021 ident: 568_CR1 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 contributor: fullname: H Sung – volume: 124 start-page: 2626 year: 2014 ident: 568_CR211 publication-title: J. Clin. Invest. doi: 10.1172/JCI74056 contributor: fullname: T Condamine – volume: 11 start-page: 3736 year: 2020 ident: 568_CR66 publication-title: J. Cancer doi: 10.7150/jca.42953 contributor: fullname: Y Wang – volume: 98 start-page: 349 year: 1999 ident: 568_CR94 publication-title: Acta Neuropathol. doi: 10.1007/s004010051093 contributor: fullname: G Fossati – volume: 21 start-page: 2212 year: 2017 ident: 568_CR174 publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.10.104 contributor: fullname: E Hawila – volume: 183 start-page: 1282 year: 2020 ident: 568_CR13 publication-title: Cell doi: 10.1016/j.cell.2020.10.003 contributor: fullname: I Ballesteros – volume: 66 start-page: 743 year: 2017 ident: 568_CR106 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.12.011 contributor: fullname: A Mohs – volume: 30 start-page: 126899 year: 2020 ident: 568_CR173 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2019.126899 contributor: fullname: S Peddibhotla – volume: 67 start-page: 931 year: 2018 ident: 568_CR125 publication-title: Gut doi: 10.1136/gutjnl-2017-314032 contributor: fullname: J Zhou – volume: 62 start-page: 534 year: 2015 ident: 568_CR207 publication-title: Hepatology doi: 10.1002/hep.27859 contributor: fullname: J Lo – volume: 16 start-page: 601 year: 2019 ident: 568_CR14 publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/s41571-019-0222-4 contributor: fullname: ME Shaul – volume: 30 start-page: 5663 year: 2020 ident: 568_CR65 publication-title: Eur. Radiol. doi: 10.1007/s00330-020-06931-5 contributor: fullname: IT Schobert – volume: 225 start-page: 438 year: 2011 ident: 568_CR93 publication-title: J. Pathol. doi: 10.1002/path.2947 contributor: fullname: Y Wu – volume: 120 start-page: 2423 year: 2010 ident: 568_CR102 publication-title: J. Clin. Invest. doi: 10.1172/JCI41649 contributor: fullname: KJ Eash – volume: 9 start-page: 162 year: 2009 ident: 568_CR46 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2506 contributor: fullname: DI Gabrilovich – volume: 7 start-page: 837 year: 2017 ident: 568_CR68 publication-title: Mol. Clin. Oncol. doi: 10.3892/mco.2017.1416 contributor: fullname: J Yuan – volume: 123 start-page: 1911 year: 2013 ident: 568_CR145 publication-title: J. Clin. Invest. doi: 10.1172/JCI66024 contributor: fullname: T Yamashita – volume: 33 year: 2019 ident: 568_CR63 publication-title: Clin. Transpl. doi: 10.1111/ctr.13743 contributor: fullname: JC McVey – ident: 568_CR240 – volume: 27 start-page: 553 year: 2014 ident: 568_CR172 publication-title: Int. J. Immunopathol. Pharmacol. doi: 10.1177/039463201402700411 contributor: fullname: JM Xu – volume: 72 start-page: 3546 year: 2012 ident: 568_CR83 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-11-4032 contributor: fullname: Q Gao – volume: 23 start-page: 5187 year: 2017 ident: 568_CR200 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-0741 contributor: fullname: A Orillion – volume: 15 start-page: 536 year: 2018 ident: 568_CR225 publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-018-0033-6 contributor: fullname: ZJ Brown – volume: 23 start-page: 1255 year: 2015 ident: 568_CR231 publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2014.6108 contributor: fullname: B Pulli – volume: 33 year: 2019 ident: 568_CR90 publication-title: J. Clin. Lab. Anal. doi: 10.1002/jcla.22872 contributor: fullname: Y Wang – ident: 568_CR196 – volume: 359 start-page: 378 year: 2008 ident: 568_CR160 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0708857 contributor: fullname: JM Llovet – volume: 37 start-page: 273 year: 2016 ident: 568_CR128 publication-title: Trends Immunol. doi: 10.1016/j.it.2016.03.006 contributor: fullname: S Nourshargh – volume: 10 start-page: 1696 year: 2020 ident: 568_CR227 publication-title: Front. Oncol. doi: 10.3389/fonc.2020.01696 contributor: fullname: H Tian – volume: 17 start-page: 457 year: 2020 ident: 568_CR41 publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-020-0304-x contributor: fullname: P Ramachandran – volume: 23 start-page: 3946 year: 2018 ident: 568_CR159 publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.05.082 contributor: fullname: HL Matlung – volume: 38 start-page: 193 year: 2020 ident: 568_CR17 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.19.01307 contributor: fullname: RS Finn – volume: 69 start-page: 222 year: 2019 ident: 568_CR109 publication-title: Hepatology doi: 10.1002/hep.30166 contributor: fullname: C Haider – volume: 5 start-page: 641 year: 2005 ident: 568_CR141 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1668 contributor: fullname: V Bronte – volume: 34 start-page: 129 year: 2015 ident: 568_CR84 publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-015-0247-1 contributor: fullname: L Li – volume: 24 start-page: 4834 year: 2018 ident: 568_CR47 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-3726 contributor: fullname: S Lang – volume: 144 start-page: 136 year: 2019 ident: 568_CR221 publication-title: Int. J. Cancer doi: 10.1002/ijc.31808 contributor: fullname: E Pylaeva – volume: 9 start-page: 664 year: 2019 ident: 568_CR85 publication-title: Front. Oncol. doi: 10.3389/fonc.2019.00664 contributor: fullname: W Li – volume: 57 start-page: 1115 year: 2016 ident: 568_CR57 publication-title: Yonsei Med. J. doi: 10.3349/ymj.2016.57.5.1115 contributor: fullname: XG Hu – volume: 60 start-page: 179 year: 2014 ident: 568_CR206 publication-title: Hepatology doi: 10.1002/hep.27070 contributor: fullname: TK Lee – ident: 568_CR101 – ident: 568_CR239 – volume: 6 year: 2015 ident: 568_CR115 publication-title: Nat. Commun. doi: 10.1038/ncomms7818 contributor: fullname: CL Wilson – volume: 117 start-page: 28960 year: 2020 ident: 568_CR177 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.2013644117 contributor: fullname: D Biasci – volume: 122 start-page: 3127 year: 2012 ident: 568_CR169 publication-title: J. Clin. Invest. doi: 10.1172/JCI61067 contributor: fullname: T Jamieson – volume: 80 start-page: 2012 year: 1992 ident: 568_CR12 publication-title: Blood doi: 10.1182/blood.V80.8.2012.2012 contributor: fullname: F Colotta – volume: 129 start-page: 2183 year: 2011 ident: 568_CR98 publication-title: Int. J. Cancer doi: 10.1002/ijc.25892 contributor: fullname: S Trellakis – volume: 21 start-page: 135 year: 2020 ident: 568_CR54 publication-title: Nat. Immunol. doi: 10.1038/s41590-019-0571-2 contributor: fullname: JM Adrover – volume: 18 start-page: 4301 year: 1998 ident: 568_CR185 publication-title: Mol. Cell Biol. doi: 10.1128/MCB.18.7.4301 contributor: fullname: HS Radomska – volume: 7 start-page: 1131 year: 1993 ident: 568_CR194 publication-title: Leukemia contributor: fullname: E Vellenga – volume: 5 start-page: 3 year: 2017 ident: 568_CR45 publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-16-0297 contributor: fullname: DI Gabrilovich – volume: 20 start-page: 287 year: 2005 ident: 568_CR135 publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2004.03575.x contributor: fullname: Y Imai – ident: 568_CR204 – ident: 568_CR4 – volume: 360 start-page: 302 year: 2015 ident: 568_CR208 publication-title: Cancer Lett. doi: 10.1016/j.canlet.2015.02.036 contributor: fullname: Z Xiao – volume: 26 year: 2020 ident: 568_CR58 publication-title: Med. Sci. Monit. doi: 10.12659/MSM.918824 contributor: fullname: W Kong – volume: 16 start-page: 440 year: 2016 ident: 568_CR219 publication-title: BMC Cancer doi: 10.1186/s12885-016-2481-0 contributor: fullname: A Deronic – volume: 9 year: 2018 ident: 568_CR104 publication-title: Cell Death Dis. doi: 10.1038/s41419-018-0458-4 contributor: fullname: Y Cheng – volume: 52 start-page: 856 year: 2020 ident: 568_CR148 publication-title: Immunity doi: 10.1016/j.immuni.2020.03.001 contributor: fullname: Á Teijeira – volume: 17 start-page: 433 year: 2020 ident: 568_CR103 publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-020-0412-0 contributor: fullname: M Metzemaekers – volume: 35 start-page: 502 year: 2015 ident: 568_CR72 publication-title: Liver Int. doi: 10.1111/liv.12688 contributor: fullname: JA Leithead – volume: 23 start-page: 2942 year: 2017 ident: 568_CR212 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-16-1784 contributor: fullname: GA Dominguez – volume: 16 start-page: 183 year: 2009 ident: 568_CR23 publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.06.017 contributor: fullname: ZG Fridlender – volume: 5 year: 2016 ident: 568_CR34 publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1232221 contributor: fullname: ME Shaul – volume: 50 start-page: 924 year: 2019 ident: 568_CR144 publication-title: Immunity doi: 10.1016/j.immuni.2019.03.024 contributor: fullname: E Batlle – volume: 12 start-page: 3341 year: 2021 ident: 568_CR43 publication-title: Nat. Commun. doi: 10.1038/s41467-021-23667-y contributor: fullname: EM Schoof – volume: 72 start-page: 913 year: 2012 ident: 568_CR218 publication-title: Prostate doi: 10.1002/pros.21495 contributor: fullname: K Jennbacken – volume: 54 start-page: 497 year: 2011 ident: 568_CR86 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2010.07.044 contributor: fullname: YW Li – volume: 9 start-page: 113 year: 2018 ident: 568_CR8 publication-title: Front. Physiol. doi: 10.3389/fphys.2018.00113 contributor: fullname: C Rosales – volume: 10 start-page: 1912 year: 2019 ident: 568_CR51 publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.01912 contributor: fullname: JBG Mackey – volume: 115 start-page: 211 year: 2015 ident: 568_CR163 publication-title: Radiother. Oncol. doi: 10.1016/j.radonc.2015.04.006 contributor: fullname: A Huertas – volume: 18 start-page: 38 year: 2021 ident: 568_CR9 publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-020-00560-0 contributor: fullname: K Liu – volume: 63 start-page: 420 year: 2015 ident: 568_CR132 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.03.024 contributor: fullname: C Yan – volume: 10 start-page: 562 year: 2015 ident: 568_CR33 publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.12.039 contributor: fullname: JY Sagiv – volume: 5 year: 2016 ident: 568_CR92 publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1219828 contributor: fullname: M He – volume: 522 start-page: 349 year: 2015 ident: 568_CR156 publication-title: Nature doi: 10.1038/nature14407 contributor: fullname: V Finisguerra – volume: 10 year: 2019 ident: 568_CR184 publication-title: Clin. Transl. Gastroenterol. doi: 10.14309/ctg.0000000000000056 contributor: fullname: RK Kelley – volume: 176 start-page: 1271 year: 2010 ident: 568_CR232 publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2010.090527 contributor: fullname: MW Harty – volume: 30 start-page: 120 year: 2016 ident: 568_CR157 publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.06.001 contributor: fullname: S Singhal – volume: 10 start-page: 3130 year: 2019 ident: 568_CR229 publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.03130 contributor: fullname: J Stackowicz – volume: 50 start-page: 799 year: 2009 ident: 568_CR134 publication-title: Hepatology doi: 10.1002/hep.23054 contributor: fullname: B Hoechst – volume: 8 start-page: 24380 year: 2017 ident: 568_CR59 publication-title: Oncotarget doi: 10.18632/oncotarget.15456 contributor: fullname: X Li – volume: 382 start-page: 1894 year: 2020 ident: 568_CR15 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1915745 contributor: fullname: RS Finn – volume: 9 year: 2018 ident: 568_CR39 publication-title: Nat. Commun. doi: 10.1038/s41467-018-07505-2 contributor: fullname: CM Rice – volume: 5 year: 2016 ident: 568_CR222 publication-title: OncoImmunology doi: 10.1080/2162402X.2015.1067744 contributor: fullname: S Shrestha – volume: 22 year: 2020 ident: 568_CR82 publication-title: J. Gene Med. doi: 10.1002/jgm.3155 contributor: fullname: W Chen – volume: 148 start-page: 1383 year: 2015 ident: 568_CR190 publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.02.055 contributor: fullname: JH Lee – volume: 43 start-page: 757 year: 2013 ident: 568_CR60 publication-title: Hepatol. Res. doi: 10.1111/hepr.12019 contributor: fullname: AR Limaye – volume: 10 start-page: 2657 year: 2019 ident: 568_CR44 publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02657 contributor: fullname: H Baharlou – volume: 56 start-page: 2242 year: 2012 ident: 568_CR91 publication-title: Hepatology doi: 10.1002/hep.25907 contributor: fullname: SL Zhou – volume: 368 start-page: 973 year: 2020 ident: 568_CR236 publication-title: Science doi: 10.1126/science.aay9189 contributor: fullname: D Nejman – volume: 486 start-page: 239 year: 2017 ident: 568_CR179 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2017.02.128 contributor: fullname: H Liu – volume: 170 start-page: 3233 year: 2003 ident: 568_CR119 publication-title: J. Immunol. doi: 10.4049/jimmunol.170.6.3233 contributor: fullname: C Ryckman – volume: 8 year: 2017 ident: 568_CR121 publication-title: Nat. Commun. doi: 10.1038/s41467-017-00530-7 contributor: fullname: DK Chiu – volume: 6 start-page: 846 year: 2015 ident: 568_CR111 publication-title: Oncotarget doi: 10.18632/oncotarget.2749 contributor: fullname: WR Liu – volume: 170 start-page: 1027 year: 2003 ident: 568_CR213 publication-title: J. Immunol. doi: 10.4049/jimmunol.170.2.1027 contributor: fullname: SA Renshaw – volume: 118 start-page: 2476 year: 2012 ident: 568_CR97 publication-title: Cancer doi: 10.1002/cncr.26511 contributor: fullname: TO Jensen – volume: 25 start-page: 2705 year: 2017 ident: 568_CR186 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.07.018 contributor: fullname: J Voutila – volume: 12 start-page: 7173 year: 2020 ident: 568_CR56 publication-title: Cancer Manag. Res. doi: 10.2147/CMAR.S257934 contributor: fullname: L Guo – volume: 182 start-page: 240 year: 2009 ident: 568_CR137 publication-title: J. Immunol. doi: 10.4049/jimmunol.182.1.240 contributor: fullname: H Li – volume: 25 start-page: 435 year: 2013 ident: 568_CR71 publication-title: Eur. J. Gastroenterol. Hepatol. doi: 10.1097/MEG.0b013e32835c2af3 contributor: fullname: M Biyik – volume: 8 start-page: 3098 year: 2015 ident: 568_CR77 publication-title: Int. J. Clin. Exp. Med. contributor: fullname: B Peng – volume: 6 start-page: 26 year: 2020 ident: 568_CR10 publication-title: Cell Death Discov. doi: 10.1038/s41420-020-0255-6 contributor: fullname: C Brostjan – volume: 45 start-page: 949 year: 2015 ident: 568_CR69 publication-title: Hepatol. Res. doi: 10.1111/hepr.12436 contributor: fullname: T Terashima – volume: 18 start-page: 1414 year: 2017 ident: 568_CR199 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms18071414 contributor: fullname: T Eckschlager – volume: 2 start-page: 561 year: 2000 ident: 568_CR28 publication-title: Neoplasia doi: 10.1038/sj.neo.7900110 contributor: fullname: AS Haqqani – volume: 6 year: 2016 ident: 568_CR75 publication-title: Sci. Rep. doi: 10.1038/srep22089 contributor: fullname: X Gu – volume: 62 start-page: 131 year: 2015 ident: 568_CR138 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2014.08.023 contributor: fullname: XF Li – volume: 120 start-page: 1240 year: 1978 ident: 568_CR153 publication-title: J. Immunol. doi: 10.4049/jimmunol.120.4.1240 contributor: fullname: AM Dvorak – volume: 2017 start-page: 7989020 year: 2017 ident: 568_CR35 publication-title: J. Immunol. Res. doi: 10.1155/2017/7989020 contributor: fullname: SM Toor – volume: 64 start-page: 797 year: 2016 ident: 568_CR105 publication-title: Hepatology doi: 10.1002/hep.28655 contributor: fullname: DK Chiu – volume: 70 start-page: 1564 year: 2019 ident: 568_CR110 publication-title: Hepatology doi: 10.1002/hep.30676 contributor: fullname: YM Li – volume: 70 start-page: 1214 year: 2019 ident: 568_CR113 publication-title: Hepatology doi: 10.1002/hep.30630 contributor: fullname: SL Zhou – volume: 172 start-page: 989 year: 2004 ident: 568_CR40 publication-title: J. Immunol. doi: 10.4049/jimmunol.172.2.989 contributor: fullname: S Kusmartsev – volume: 95 year: 2016 ident: 568_CR61 publication-title: Medicine doi: 10.1097/MD.0000000000002722 contributor: fullname: SD Lu – volume: 7 year: 2017 ident: 568_CR187 publication-title: Sci. Rep. doi: 10.1038/s41598-017-12968-2 contributor: fullname: JR Mackert – volume: 21 year: 2019 ident: 568_CR243 publication-title: Breast Cancer Res. doi: 10.1186/s13058-019-1237-6 contributor: fullname: HT Snoderly – volume: 73 start-page: 906 year: 2020 ident: 568_CR112 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.05.004 contributor: fullname: ZP Peng – volume: 114 start-page: 612 year: 2016 ident: 568_CR74 publication-title: Br. J. Cancer doi: 10.1038/bjc.2016.23 contributor: fullname: T Grenader – volume: 569 start-page: 73 year: 2019 ident: 568_CR50 publication-title: Nature doi: 10.1038/s41586-019-1118-2 contributor: fullname: F Veglia – volume: 9 start-page: 1298 year: 2018 ident: 568_CR114 publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.01298 contributor: fullname: S Wang – volume: 78 start-page: 157 year: 2018 ident: 568_CR24 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-17-0348 contributor: fullname: C Blattner – volume: 276 start-page: 145 year: 2017 ident: 568_CR205 publication-title: Immunol. Rev. doi: 10.1111/imr.12527 contributor: fullname: HL Matlung – volume: 15 start-page: 2651 year: 2014 ident: 568_CR79 publication-title: Asian Pac. J. Cancer Prev. doi: 10.7314/APJCP.2014.15.6.2651 contributor: fullname: Y Kemal – volume: 9 start-page: 3017 year: 2016 ident: 568_CR80 publication-title: Onco Targets Ther. contributor: fullname: HL Sun – volume: 183 start-page: 771 year: 2020 ident: 568_CR154 publication-title: Cell doi: 10.1016/j.cell.2020.09.058 contributor: fullname: L Kalafati – volume: 5 year: 2016 ident: 568_CR136 publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1234565 contributor: fullname: S Lacotte – volume: 118 start-page: 248 year: 2018 ident: 568_CR62 publication-title: Br. J. Cancer doi: 10.1038/bjc.2017.386 contributor: fullname: J Margetts – volume: 36 start-page: 342 year: 2002 ident: 568_CR233 publication-title: J. Hepatol. doi: 10.1016/S0168-8278(01)00276-8 contributor: fullname: J Taïeb – volume: 39 start-page: 267 year: 2021 ident: 568_CR18 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2021.39.3_suppl.267 contributor: fullname: RS Finn – volume: 61 start-page: 1155 year: 2012 ident: 568_CR21 publication-title: Cancer Immunol. Immunother. doi: 10.1007/s00262-012-1294-5 contributor: fullname: CA Dumitru – volume: 180 start-page: 5771 year: 2008 ident: 568_CR143 publication-title: J. Immunol. doi: 10.4049/jimmunol.180.9.5771 contributor: fullname: KN Couper – volume: 116 start-page: 1831 year: 2015 ident: 568_CR19 publication-title: J. Cell Biochem. doi: 10.1002/jcb.25124 contributor: fullname: LO Carvalho – volume: 130 start-page: 1433 year: 2000 ident: 568_CR195 publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0703452 contributor: fullname: BL Webb – volume: 7 year: 2012 ident: 568_CR27 publication-title: PLoS ONE doi: 10.1371/journal.pone.0031524 contributor: fullname: ZG Fridlender – volume: 20 start-page: 485 year: 2020 ident: 568_CR238 publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-020-0281-y contributor: fullname: S Jaillon – volume: 27 start-page: 4709 year: 2009 ident: 568_CR96 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2008.18.9498 contributor: fullname: HK Jensen – volume: 13 year: 2018 ident: 568_CR220 publication-title: PLoS ONE doi: 10.1371/journal.pone.0203228 contributor: fullname: N Fransén Pettersson – volume: 112 start-page: E566 year: 2015 ident: 568_CR52 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1424927112 contributor: fullname: A-J Casbon – volume: 124 start-page: 5466 year: 2014 ident: 568_CR26 publication-title: J. Clin. Invest. doi: 10.1172/JCI77053 contributor: fullname: EB Eruslanov – volume: 12 start-page: 912 year: 2020 ident: 568_CR88 publication-title: Aging doi: 10.18632/aging.102665 contributor: fullname: Y Liu – volume: 65 start-page: 280 year: 2016 ident: 568_CR197 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.02.043 contributor: fullname: M Bitzer – volume: 3 start-page: 80 year: 2020 ident: 568_CR209 publication-title: Antib. Ther. contributor: fullname: AR Jalil – volume: 3 start-page: 136 year: 2015 ident: 568_CR217 publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-14-0036 contributor: fullname: L Shen – volume: 7 start-page: 50963 year: 2016 ident: 568_CR76 publication-title: Oncotarget doi: 10.18632/oncotarget.7680 contributor: fullname: G Lin – ident: 568_CR171 – volume: 65 start-page: 3044 year: 2005 ident: 568_CR49 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-4505 contributor: fullname: AH Zea – volume: 120 start-page: 69 year: 2019 ident: 568_CR161 publication-title: Br. J. Cancer doi: 10.1038/s41416-018-0198-3 contributor: fullname: LM Schiffmann – ident: 568_CR203 – volume: 154 start-page: 50 year: 2018 ident: 568_CR228 publication-title: Immunology doi: 10.1111/imm.12906 contributor: fullname: JK Skelton – volume: 19 start-page: 222 year: 2018 ident: 568_CR5 publication-title: Nat. Immunol. doi: 10.1038/s41590-018-0044-z contributor: fullname: M Ringelhan – ident: 568_CR42 doi: 10.1101/2020.12.22.423933 – volume: 29 start-page: 832 year: 2016 ident: 568_CR170 publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.04.014 contributor: fullname: CW Steele – volume: 108 start-page: 914 year: 2013 ident: 568_CR95 publication-title: Br. J. Cancer doi: 10.1038/bjc.2013.32 contributor: fullname: Y Ino – volume: 24 year: 2019 ident: 568_CR166 publication-title: JCI Insight doi: 10.1172/jci.insight.130850 contributor: fullname: J Kargl – volume: 10 start-page: 1419 year: 2019 ident: 568_CR224 publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.01419 contributor: fullname: S Sody – volume: 168 start-page: 689 year: 2002 ident: 568_CR142 publication-title: J. Immunol. doi: 10.4049/jimmunol.168.2.689 contributor: fullname: A Mazzoni – volume: 78 start-page: 2680 year: 2018 ident: 568_CR155 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-17-3614 contributor: fullname: M Gershkovitz – volume: 1835 start-page: 100 year: 2013 ident: 568_CR215 publication-title: Biochim. Biophys. Acta contributor: fullname: J Markowitz – volume: 237 start-page: 85 year: 2015 ident: 568_CR168 publication-title: J. Pathol. doi: 10.1002/path.4555 contributor: fullname: CW Steele |
SSID | ssj0065539 |
Score | 2.6477168 |
SecondaryResourceType | review_article |
Snippet | The success of atezolizumab plus bevacizumab treatment contributed to a shift in systemic therapies for hepatocellular carcinoma (HCC) towards combinations... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 257 |
SubjectTerms | 631/67/1059 631/67/1504/1610/4029 692/4020/1503/1607/1610/4029 692/4020/4021/1607/1610/4029 692/4028/67/1504/1610/4029 Bevacizumab Biomedicine Cancer immunotherapy Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - pathology Clinical trials Gastroenterology Hepatocellular carcinoma Hepatology Humans Immune checkpoint Immunotherapy Leukocytes (neutrophilic) Liver cancer Liver Neoplasms - drug therapy Liver Neoplasms - pathology Lymphocytes Lymphocytes - pathology Medicine Medicine & Public Health Metastases Metastasis Neutrophils Phenotypes Review Article Therapeutic targets Tumorigenesis Tumors |
Title | Neutrophils as potential therapeutic targets in hepatocellular carcinoma |
URI | https://link.springer.com/article/10.1038/s41575-021-00568-5 https://www.ncbi.nlm.nih.gov/pubmed/35022608 https://www.proquest.com/docview/2645769230 https://search.proquest.com/docview/2619542095 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD54AfFFvFsvo4JvWpamTdo-iYpjCA4RB3srSZqioO1cu__vSZtOZehzmzT5kub7knNODsCFjAknWhtXnZB7oVbEE4oTL8uT0E-kIjIz0ciPIz4chw8TNrEHbpV1q-zWxGahzkplzsj7SNwojVGOkOvpp2eyRhnrqk2hsQrr1A-NmXb99n709NytxZyxJpcYcmTiMVQvNmyGBHG_QuqKTHQythNVQOyx39S0pDeXbKUNBQ22YctqR_emHewdWNHFLmw8Wuv4HgxHel7Pyunr23vlisqdlrXxBcIiP6Ks3Nb3u3LfCvcVuaguzdm9cUZ1lckrVJQfYh_Gg_uXu6FnMyV4ChGtsWsyoipHCBKm_IBLpcytNYnE3VUuKNWBSKI8zlH8kZxlVEpUTiLPuC9U41t4AGtFWegjcCmyZsBj1DVhHgoiZEwFlWEQ4L4Ci_oOXHYgpdP2Qoy0MWQHcdpCmiKkaQNpyhw47XBM7c9Rpd9D6cD54jFOa9NfUehybt4xV9FRFIAOHLb4Lz4XMBQenMQOXHUD8l353205_r8tJ7BJTWhD45VzCmv1bK7PUHDUsger0STq2bn1Bcw30aU |
link.rule.ids | 315,786,790,12083,21416,27955,27956,31752,31753,33777,33778,43343,43838,74100,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dT4MwFL3Rmagvxm_RqZj4psRSaAdPxhiX-bE9bcnemraUzERhCvv_3gKbmkUfCRTa09Jz2ntvL8CliggnxlhXnZB7odHEk5oTL0nj0I-VJiqx0cj9Ae-NwqcxGzcbbkXjVjmfE6uJOsm13SO_QeJGaYxyhNxOPzybNcpaV5sUGquwFgZBaMd5Z7xYcHHGqkxiyJCxx1C7NEEzJIhuCiSujo1NxlqiBog89puYltTmkqW0IqDuNmw1ytG9q7t6B1ZMtgvr_cY2vge9gZmVn_l08vpWuLJwp3lpPYGwyI8YK7f2_C7c18ydIBOVud25t66orrZZhbL8Xe7DqPswvO95TZ4ETyOeJTZNdahOfbxg2g-40tqeWRMrXFulklITyLiTRilKP5KyhCqFukmmCfelrjwLD6CV5Zk5ApciZwY8QlUTpqEkUkVUUoXY4qoCi_oOXM1BEtP6OAxRmbGDSNSQCoRUVJAK5kB7jqNofo1CfHekAxeL2ziobXtlZvKZfcYeREdR_jlwWOO_-FzAUHZwEjlwPe-Q75f_XZfj_-tyDhu9Yf9FvDwOnk9gk9ogh8o_pw2t8nNmTlF6lOqsGl9fPC3SRQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Pb5swFH5qUynapdq6tWXLVibttqIYgw2cpmlblP5ItMMq5WbZxlYrtUAL-f_3DE66qlqPCAz2s_H32e97fgBfVE44McZJdVIepUaTSGpOotIWaVwoTVTpopEXSz6_Ss9XbOX1T62XVW7mxH6iLmvt9sinCNxIjZGOkKn1sojfP2ffmvvIZZBynlafTmMX9hAliUvjkK22iy_OWJ9VDNGyiBjyGB9AQ5J82iKIZS5OGWuMfCCP2FOQesY8n3lNezCavYZ9zyLD70O3v4EdUx3AeOH95G9hvjTr7qFurm9u21C2YVN3ThWERf6JtwoHFXgb3lThNaJSV7tdfCdLDbXLMFTVd_IdXM1-_fkxj3zOhEijbTtsmsqotjFeMB0nXGntzq8pFK6zrKTUJLLIbG6RBhLLSqoUcihpSx5L3asMD2FU1ZU5hpAifiY8R4aT2lQSqXIqqUqTBFcYWDQO4OvGSKIZjsYQvUs7ycVgUoEmFb1JBQtgsrGj8L9JKx47NYDP29s4wF17ZWXqtXvGHUpHkQoGcDTYf_u5hCEF4SQP4HTTIY8v_39d3r9clxMY49ASl2fLiw_wirp4h16qM4FR97A2H5GFdOpTP7z-AiXr1nE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutrophils+as+potential+therapeutic+targets+in+hepatocellular+carcinoma&rft.jtitle=Nature+reviews.+Gastroenterology+%26+hepatology&rft.au=Geh%2C+Daniel&rft.au=Leslie%2C+Jack&rft.au=Rumney%2C+Rob&rft.au=Reeves%2C+Helen+L&rft.date=2022-04-01&rft.eissn=1759-5053&rft.volume=19&rft.issue=4&rft.spage=257&rft_id=info:doi/10.1038%2Fs41575-021-00568-5&rft_id=info%3Apmid%2F35022608&rft.externalDocID=35022608 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1759-5045&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1759-5045&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1759-5045&client=summon |